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A terapia fotodinâmica antimicrobiana (aPDT) está-se a tornar uma 
alternativa promissora para inactivar microrganismos patogénicos. Esta terapia 
consiste na combinação de três elementos não tóxicos, fotosensibilizadores 
(PS), luz e oxigénio que, quando combinados conduzem à formação de 
espécies reactivas de oxigénio altamente citotóxicas, nomeadamente o 
oxigénio singuleto. Estas espécies podem oxidar muitos tipos de moléculas 
biológicas, como o caso de proteínas, ácidos nucleicos e lípidos. A 
combinação de grupos com cargas positivas e hidratos de carbono com 
derivados porfirínicos resulta num aumento de reconhecimento celular e 
solubilidade em água, melhorando a penetração na membrana celular e 
acumulação em compartimentos sub-celulares.  
O objectivo deste trabalho foi sintetizar novos derivados porfirínicos meso-
glicosil substituídos e avaliar a eficácia destes compostos como PS na 
fotoinactivação de duas bactérias gram positivas ambientais, Brevibacterium 
sp. e Micrococcus sp. e uma bactéria gram negativas, Escherichia coli 
bioluminescente. Brevibacterium sp. e Micrococcus sp. foram escolhidas para 
este estudo por serem, respectivamente, representantes de tipos muito 
sensíveis e resistentes a experiências de irradiação UV-B. Também foi 
avaliado o efeito do 1O2 a nível de oxidação de lipídios e proteínas, sobre as 
duas bactérias gram positivas. 
Os derivados porfirínicos meso-tetrapiridil foram cationizados com iodeto 
de metilo e unidades glicosídicas. Todos os compostos sintetizados foram 
caracterizados por ressonância magnética nuclear dos protões e fluor e por 
espectrometria de massa. Dois desses compostos sintetizados, 5,10,15,20-
tetrakis(N-methilpiridinium-4-il)porfirina tetra-iodeto (PS 1) e a 5-[N-
(isopropilidene-6-deoxi-galactopiranos-6-il)piridinium-4-il]-10,15,20-tris(N-
metilpiridinium-4-il)porfirina tetra-iodeto (PS 2), foram usados como PS nos 
estudos de aPDT. Nos estudos de aPDT foram irradiadas, após uma pré-
incubação no escuro, suspensões bacterianas puras com 0.5, 1 e 5 µmol dm-3 
de PS no caso das bactérias gram positivas, e 5 µmol dm-3 no caso da E. coli. 
A cinética de irradiação foi avaliada através da quantificação de unidades 
formadoras de colónias (UFC) colhidas durante os 15 minutos de irradiação, 
sob 150 mW cm-2. Foram incluídos controlos claros e escuros em todas as 
experiências. Foram também realizados estudos fotofísicos (Fotoestabilidade e 
Geração de 1O2). A oxidação lipídica foi avaliada através do ensaio com ácido 
tiobarbitúrico (TBA) e os resultados expressos em termos de malondialdeído 
(MDA) (nmol dm-3). A oxidação de proteínas foi avaliada através do 2,4-
dinitrofenilidrazina (DNPH) e os resultados expressos em termos de teor de 
proteína carbonilada (nmol cm-3). 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
  
  
 
 
Os ensaios de aPDT revelaram que o PS 2 foi mais eficaz (3,0 log de 
recução) do que o PS 1 (2,0 log) com 5 !mol dm-3 contra E. coli. No caso das 
bactérias gram positivas, ambos os PS demonstraram o mesmo efeito de 
fotoinactivação, apresentando uma inativação completa após 2 minutos de 
irradiação. No entanto, nas menores concentrações o PS 1 mostrou ser mais 
eficaz do que o PS 2 em ambas as bactérias gram positivas. Os estudos 
fotofísicos demonstraram que ambos os PS são fotoestáveis e bons 
produtores de 1O2. Os ensaios de peroxidação lipídica apresentaram 
resultados diferentes para ambas as bactérias ambientais. No Micrococcus 
não foi observada oxidação lipídica com PS 1, enquanto com o PS 2 foi 
observado cerca de 31% de oxidação lipídica (0,083 nmol dm-3). No 
Brevibacterium o PS 1 causou 28% (0,063 nmol dm-3) e o PS 2 50% (0,093 
nmol dm-3) de peroxidação lipídica. De acordo com os resultados de oxidação 
de proteínas, o Micrococcus apresentou cerca de 2,1 nmol mL-1 e 6,2 nmol mL-
1 de carbonilação de proteínas com o PS 1 e 2, respectivamente. No caso de 
Brevibacterium foram observados 5,0 nmol mL-1 e 4,8 nmol mL-1 com o PS 1 e 
2, respectivamente. 
Ambas as porfirinas mostraram bons resultados tanto na fotoinactivação 
bactérias gram negativa como nas gram positivas. A suscetibilidade do 
Brevibacterium sp. e Micrococcus sp. na aPDT foi diferente dos resultados 
observados na radiação UV-B, por estas mesmas bactérias. Os ensaios de 
oxidação lipídica permitiu concluir que, no caso Brevibacterium ambos os PS 
actuam na membrana plasmática, enquanto que no Micrococcus estes danos 
só acontecem com o PS 2. A oxidação de proteínas levou à conclusão que os 
danos a nível das proteínas podem ter ocorrido devido à oxidação lipídica, ou 
interação directa entre o 1O2 e as proteínas. 
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abstract 
 
Antimicrobial photodynamic therapy (aPDT) is becoming a promising 
alternative to inactivate microbial pathogens. This therapy combines three non-
toxic components, a photosensitizer (PS), light and oxygen, that when 
combined leads to the formation of highly cytotoxic reactive oxygen species, 
mainly singlet oxygen (1O2). This specie can oxidize many types of biological 
molecules, such as proteins, nucleic acids and lipids. The combination of 
positively charged groups and carbohydrate moieties with porphyrin derivatives 
results in an increased cell recognition and water solubility, which improves cell 
membrane penetration and accumulation in sub-cellular compartments.  
The aim of this work was to synthesize new meso-substituted glycosyl 
porphyrins derivatives and evaluated the efficacy of these compounds as PS in 
the photoinactivation of two environmental gram positive bacteria, 
Brevibacterium sp. and Micrococcus sp., and one gram negative bacteria, 
bioluminescent Escherichia coli. Brevibacterium sp. and Micrococcus sp were 
chosen for these studies because they were, respectively, representative of 
very sensitive and very resistant types to UV-B irradiation experiments. It was 
also evaluated the effect of 1O2 at the lipid and protein oxidation level, 
generated during the aPDT assay, on the two gram positive bacteria.  
The derivatives of meso-tetrapyridyl porphyrin were cationized by methyl 
iodide or by carbohydrate moieties. All synthesized compounds were 
characterized by proton and fluor nuclear magnetic resonance and by mass 
spectrometry. Two of the compounds synthesized 5,10,15,20-tetrakis(N-
methylpyridinium-4-yl)porphyrin tetra-iodide (PS 1) and 5-[N-(Isopropylidene-6-
deoxy-galactopyranos-6-yl)pyridinium-4-yl]-10,15,20-tris(N-methylpyridinium-4-
yl)porphyrin tetra-iodide (PS 2) were used as PS in the aPDT assays. For the 
aPDT assays pure bacterial suspensions were irradiated after pre-incubation in 
the dark, at concentrations of 0.5, 1 and 5 µmol dm-3 of PS in the case of gram 
positive bacteria, and 5 µmol dm-3 in the case of gram negative bacteria. The 
kinetics of irradiation was evaluated by the quantification of colony forming 
units in aliquots collected during 15 minutes of irradiation, under 150 mW cm-2. 
Light and dark controls were included in all experiments. Photophysical testes 
(photostability and 1O2 genereation studies) were also performed. Lipid 
oxidation was assessed by Tiobarbituric acid (TBA) assay and results were 
expressed in terms of Malondialdehyde (MDA) (nmol dm-3). Protein oxidation 
was evaluated by 2,4-dinitrophenylhydrazine (DNPH) assay and results were 
expressed in terms of Protein carbonyl concentration (nmol cm-3). 
aPDT assays revealed that PS 2 was more effective (3.0 log of reduction) 
than the PS 1 (2.0 log) with 5 µmol dm-3  against E. coli. In the case of gram 
positive bacteria, both PS showed the same photoinactivation effect, 
presenting complete inactivation after 2 minutes of irradiation. However, with 
lower concentration PS 1 showed to be more effective than PS 2 in both gram 
positive bacteria. Photophysical studies showed that both PS are photostable 
and good 1O2 producers. 
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 Lipid peroxidation assays displayed different results for both environmental 
bacteria. In Micrococcus no lipid oxidation was observed with PS 1 while with 
PS 2 was observed around 31% of lipid oxidation (0.083 nmol dm-3). In 
Brevibacterium PS 1 caused 28% (0.063 nmol dm-3) and PS 2 50% (0.093 
nmol dm-3) of lipid peroxidation. According to the protein oxidation results, 
Micrococcus showed around 2.1 nmol mL-1 and 6.2 nmol mL-1 of protein 
carbonyls with PS 1 and 2, respectively. In the case of Brevibacterium 5.0 nmol 
mL-1 and 4.8 nmol mL-1 were observed with PS 1 and 2, respectively. 
Both porphyrins showed good photoinactivation results on gram negative 
and gram positive bacteria. Susceptibility of Brevibacterium sp. and 
Micrococcus sp. to aPDT were different to those showed in UV-B irradiation by 
these same bacteria. Lipid oxidation assays allowed to conclude that, in 
Brevibacterium, both PS act in plasma membrane while in Micrococcus this 
only happens with the PS with a carbohydrate moiety. Protein oxidation led to 
the conclusion that protein damage may have occurred due to lipid oxidation or 
direct interaction of 1O2 with proteins. 
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 3 
1.1 Photodynamic Effect – Brief history 
 
 Light is essential for life however, we took it for granted and forget all its 
benefits. Sunlight was employed to treat skin diseases, rickets and even psychosis 
thousands years ago, in ancient civilizations. However, only recently the benefits 
of light were applied in medicine. In the early 90’s, a medical student, Oscar Raab, 
observed the dead of Paramecium caudatum after light exposure in the presence 
of a dye, acridine orange [1]. Raab discovered that the conjugation of these two 
factors (light and dye) was greater together than separately. During his researches 
he concluded that acridine possess some product that induced in vitro toxicity, 
suggesting that this effect was caused by the energy transfer from light to the 
chemical molecule. With this discovery von Tappeiner, one of the pioneers of 
photobiology introduced in 1907 the term “photodynamic effect”. Photodynamic 
effect depends on a light source, an oxidizing agent (molecular oxygen [O2]) and 
an intermediary agent (photosensitizer [PS]) to the formation of highly cytotoxic 
species (singlet oxygen [1O2], hydrogen peroxide [H2O2], superoxide [O2
-], 
hydroxyl radicals [-OH!]) causing damage or destruction of live tissues or cells 
[2,3,4]. In fact, von Tappeiner also attempted the first known clinical application, in 
1903, with the treatment of malignant skin lesions (Figure 1.1) [5]. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 First documented patient treated with eosin and sunlight for skin lesions. Left picture 
before, and right picture after the treatment [5]. 
 
 
 
Among these are Foscan or mTHPC, the most potent photosensitizer, and
5-ALA, which probably causes the least side effects.21–23 The light-induced
fluorescence of ALA in particular has been studied for its potential diagnostic
value.24–26
PDT and fluorescence diagnosis (FD) using ALA offer several clinically
significant advantages, and they have been studied extensively in preclinical
and clinical investigations since 1987.27,28 The first indications that ALA might
be a promising drug for PDT came from five independent sources:
In 1987, Zvi Malik and H. Lugaci29 reported the use of 5-ALA to induce
endogenous porphyrin synthesis in Friend erythroleukaemic cells. Photoirra-
diation of the cells with ‘black light’-induced deformations and cell disintegra-
tion in more than 95% of the cells when examined by scanning electron
microscopy (SEM) (Figure 2). The dependence of the process on the dose of
light showed a relationship between the photodynamic effect and porphyrin
accumulation. Both necrotic and apoptotic features were expressed, including
disintegration of the plasma membrane (shown in Figure 2d and e), mi-
tochondrial damage (Figure 3b), chromatin condensation and blebbing of the
nuclear envelope (Figure 2e and f).
Mohammed El-Far had discussed in meetings30 the possibility of using ALA,
but had not published his results.
Also in 1987, Johan Moan reported an evaluation of 5-ALA as a photosen-
sitizer in mice. However, he failed to find photosensitizing concentrations of
porphyrins in either tumours or normal tissues.31
Having investigated ALA-stimulated porphyrin synthesis in plant tissues as
early as 1975,32 Alcira del Batlle in Buenos Aires reported on tumor selective
build-up of porphyrins in ALA-incubated tissue-explants in 1988.33
Figure 1. ‘Photograms’ of the first-documented patient treated with eosin and sunlight
for ‘multiple carcinomas’ of the skin (70-year-old ‘daytaller’s widow’). Left picture was
taken on Sept. 10, 1903 and right picture on November 14, 1903.
19BASIC PRINCIPLES
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1.2 Photodynamic Therapy 
 
 The use of photodynamic therapy (PDT) as a therapeutic modality gained 
relevance in the last decades and it was approved for the treatment of several 
tumours in many countries (Europe, Japan, Canada and USA) [2]. In fact, the 
greater advances in this therapy were achieved in 1976 with a study involving 
patients with bladder cancer [6]. This therapy involved a systemic, topical or direct 
administration into the organ of a chemical compound (photosensitizer) and the 
irradiation of target cells with appropriate wavelength (normally visible light and 
laser light directed via optical fibre). The combination of these two non-toxic 
elements – light and photosensitizer – in the presence of an oxygenated 
environment results on the selective destruction of tissues or cells through a 
localized cytotoxic effect [7,8]. These damages are due to the formation of 
cytotoxic reactive oxygen species (ROS) generated by the transference of light 
energy to molecular oxygen, by the photosensitizer [9]. 
 In the last two decades, significant improvements in the field of PDT made 
possible the use of this therapy in clinical treatments. The recognition of the need 
for a larger variety of photosensitizers with improved optical and target localization 
properties and a more complete understanding of biological mechanisms, 
increased the potential applications of PDT. As a consequence, PDT is now 
considered as a platform technology with broad applications in different medical 
specialties [10]. Most of clinical trials have been made with Photofrin", the first PS 
approved for the treatment of some cancers. Photofrin" is a slightly purified form of 
a hematoporphyrin derivative (HPD), a mixture of porphyrin polymers formed by 
acid treatment of hematoporphyrin [10]. While the initial focus of PDT was the 
treatment of cancer, a rapid increase in studies investigating the use of this 
therapy for the treatment of non-cancer disease was registered [10]. In fact, the 
use of PDT to treat age-macular degeneration is one of the most successful 
applications until now. Table 1.1 summarizes some of these applications, in 
various pre-clinical and clinical stages.  
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Table 1.1 Some non-cancer diseases where PDT is applied [10]. 
Cardiology Atherosclerosis 
Dermatology Psoriasis 
Actinic keratocis 
Gynecology Endometriosis 
Microbiology 
Infection control 
Peridontal disease 
Ophthalmology Age related macular degeneration 
Blood banking Sterilization of blood products 
 
 
1.3 Antimicrobial Photodynamic Therapy 
 
Despite the enormous advances in medicine over the past 100 years, 
microbial diseases are still a major problem for human health. New approaches 
that are effective, affordable and widely applicable and that are not susceptible to 
resistance are urgently needed. 
Antimicrobial photodynamic therapy (aPDT) appears for the first time in the 
90’s with the inactivation of Paramecium caudatum. This therapy follows the same 
concept as PDT, using a photosensitizer subsequently activated by low doses of 
visible light, of an appropriate wavelength, to generate free radicals or singlet 
oxygen to inactivate microorganisms [4,2,11,12,13,14]. However, the potential of 
aPDT was not exploited until the middle of last century due to the discovery of 
antibiotics. The appearance of antibiotics raised the belief that pathogenic 
microorganisms would have been reduced to a level that no longer had serious 
impacts to human health. The widespread use and the inappropriate or excessive 
prescription of antibiotics made possible for some pathogenic microorganisms to 
develop resistance against those who were initially effective [2]. This, combined 
with the appearance of microbial cells with a large variety of mechanisms against 
external insults is putting an end to the “antibiotic era” [15,16]. In the 60´s, gram 
positive bacteria and methicillin-resistant Staphylococcus aureus (MRSA) acquired 
resistance against all $-lactam antibiotics. Years later, two other cases of bacteria 
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that proved to be resistant to a new glycopeptide antibiotic, vancomycin, 
vancomycin-resistant enterococci (VRE) and vancomycin-resistant S. aureus 
(VRSA) emerged [17]. These three strains are presently major subjects of concern 
in human health. 
An enormous effort was made to find alternatives for rapid and effective 
inactivation of pathogenic microorganisms without development of new 
resistances [8]. aPDT regained interest in the search of new solutions. This 
technique is now back on focus as a promising alternative against various 
pathogenic microorganisms. Since the mode of action of the PS on microbial cells 
involves oxidative modification of vital cellular constituents, markedly different from 
that typical of most antibiotic drugs, many scientists hypothesize that development 
of resistance can be overcome [2,7,13,18].  
Currently, the most important application of aPDT is in the clinical area, 
used for sterilization of blood and blood products, as a measure of prevention of 
viral contamination [4,19,20]. Recent studies also demonstrated effectiveness as 
alternative for skin surface disinfection and treatment of superficial skin wounds, 
oral cavity infections (such as periodontitis and endodontitis) and acne vulgaris 
[8,21,22]. Several approaches have been also made for its application in 
environmental area were, several researchers groups reported effectiveness on 
the destruction of faecal bacteria, bacterial endospores, helminthes eggs and 
viruses in environmental waters [23,24,25,26,27,28,29]. This approach has been 
considered as a possible technology to treat drinking water disinfection and 
wastewater treatment plants [23,25,30]. aPDT approach represents lower costs, 
when compared with chemical compounds normally used, and is conceived to be 
environmentally-friendly and to exhibit a high level of safety of various 
ecosystems, as well for humans, animal and plants [31]. 
 
 
1.4 Porphyrins 
 
Porphyrins are a class of aromatic heterocyclic compounds with unique 
physico-chemical properties. Actually, these compounds are being used in artificial 
photosynthesis, oxidation catalysis, sensors, PDT and aPDT [32]. 
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1.4.1 Overview 
 
 Many biologic functions depend on tetrapyrrolic macrocycles compounds for 
their accomplishment. These pigments, on its reduced, rusty or complex form, may 
be designated by porphyrins, chlorins, bacteriochlorins and isobacteriochlorins 
(Figure 1.2). 
 
 
Figure 1.2 Some tetrapyrrolic units. 
 
 Respiration, photosynthesis and electron transport chains are the most 
important energetic processes carried in which tetrapyrrolic macrocycles namely 
porphyrins, are involved. The heme group (Figure 1.3), a complex iron of 
protoporphyrin-IX, discovered by Fisher in 1929, is found in proteins like 
hemoglobin, mioglobin and cytochroms. In hemoglobin and mioblogin, this 
tetrapyrrolic structure makes oxygen transport possible in the blood stream. In 
proteins like cytochrome, the heme group participates in the transfer of electrons 
and cellular production of energy [33].  
N
NH N
HN N
NH N
HN N
NH N
HN N
NH N
HN
Porphyrin Chlorin Bacteriochlorin Isobacteriochlorin
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Figure 1.3 Natural tetrapyrrolic macrocycles: a) Heme, b) Chlorophyll. 
 
 
 Hans Fischer characterized the structure of hemoglobin and chlorophyll 
(Figure 1.3) demonstrating the existence of the same porphyrinic scaffold that, 
in the case of chlorophyll, is reduced and coordinated with magnesium [34].  
 
 
1.4.2 Nomenclature of porphyrin derivatives 
 
 There are currently two systems of nomenclature that can be used for 
porphyrin macrocycles, one proposed in the 30’s by Hans Fischer and another, 
more recently proposed by the International Union of Pure and Applied 
Chemistry (IUPAC) [35]. Under the system proposed by Fischer, four pyrrole 
rings are designated by the letters A, B, C and D and their external positions 
are designated by $-pyrrolic positions. Methine bridges (inter-pyrrolic positions) 
are designated by Greek letters %, $, & and ' and are commonly known as 
meso positions (Figure 1.4). In the IUPAC nomenclature all the carbon and 
nitrogen atoms, that are part of the porphyrin macrocycle, are numbered from 1 
to 24. The hydrogen atoms linked to nitrogen atoms are in N-21 and N-23, by 
convention. However, meso and $-pyrrolic designations are still widely in use 
[35,36]. 
 
 
3
1.1 Macrociclos tetrapirrólicos – Considerações gerais
Man cannot give a true reason for the grass under his feet
why it should be green rather than red or any other color.
Sir Walter Raleigh
History of the World: Preface (1614)
Os macrociclos porfirínicos, nas suas várias formas, reduzidas, oxidadas e
complexadas estão presentes em funções vitais como a respiração, o transporte de
electrões, a fotossíntese, diversas acções enzimáticas e ainda na desintoxicação de
drogas.
1,2
 A existência de vida, tal como a concebemos hoje, requer a presença de
porfirinas.
3
Na respiração estão envolvidas as hemoproteínas, designação dada às proteínas que
apresentam, ligado à respectiva cadeia polipeptídica, um ou mais grupos prostéticos
conhecidos por heme 1.1 (fig. 1.1).
Na fotossíntese a luz é absorvida por centenas de moléculas de clorofila 1.2 (fig. 1.1)
que transferem a sua energia, resultante da fotoexcitação, para um “centro de reacção”
onde ocorre a transformação de energia lumin sa em energia química, necessária para
converter o dióxido de carbono e água em hidratos de carbono essenciais à vida.
N
N
N
N
HO2C CO2H
Fe
N
N
N
N
R
1
Mg
CO2Me
OC
O O
clorofila a: R
1
 = CH3 
clorofila b: R
1
 = CHO
cadeia lateral de fitilo
1.1
1.2
Figura 1.1 Estruturas do grupo heme 1.1 e das clorofilas a e b 1.2.
Os citocromos, responsáveis pelo transporte de electrões, são também eles
hemoproteínas, fazendo parte do grupo das biomoléculas mais antigas.
Chlorophyll : 1 = CH3 
Chlorophyll b: R1 = CHO 
!" #"
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Figure 1.4 Left: Nomenclature proposed by Hans Fisher. Right: Nomenclature proposed by 
IUPAC. 
 
 
1.4.3 Chemical and Physical properties 
 
 Porphyrins are heteroaromatic compounds characterized by a tetrapyrrole 
structure that consists in four pentagonal pyrroles linked by four methine 
bridges (Figure 1.5). This structure presents twenty-two # electrons conjugated. 
However, only eighteen electrons confer the aromatic character to this 
molecule. The four # electrons that do not contribute to the aromaticity of the 
macrocycle presenting a dual character. The elevated conjugation of # 
electrons system gives to porphyrins and derivatives an intense coloration.  
 
 
 
 
 
 
 
Figure 1.5 Structure of porphyrin Core. 
  
 The aromatic character of the macrocycle can be explained by the planar 
topology and the participation, for example, in electrophilic substitution 
reactions typical of these aromatic compounds [37,38]. Typical electrophilic 
substitution reactions of this class of compounds are for example: reactions of 
nitration, halogenation, sulfonation, formylation, acylation and deuteration [35]. 
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In addition, nucleophilic substitution, reduction and oxidation reactions can also 
occur [35]. 
 Relatively to the transformations promoted by the nitrogen atoms of the 
macrocycle, acid-base and complexation reactions with metal ions may occur. 
The acidic and basic character of the macrocycle is strongly influenced by the 
presence or absence of substituents on the periphery of the macrocycle. 
Protonation or deprotonation of the macrocycle can occur, depending if the 
macrocycle is in acidic or basic media (Scheme 1.1) [39,40]. 
 
 
 
 
 
Scheme 1.1  
 
 The photophysical and photochemical aspects, related with the structure 
as well as the aromatic character, are the most important properties of 
porphyrins. UV-Vis spectra are the most important characteristics of these 
compounds allowing their instant and precise identification. This type of 
spectrum presents two distinct regions. One absorption band, with major 
intensity around 390 – 425 nm, designated as Soret band, and two or four lower 
intensity bands – Q bands – in the region between 500 – 650 nm (Figure 1.6) – 
according to the existing macrocycle [41,42]. 
 
 
Figure 1.6 UV-vis spectra of porphyrin derivatives. 
Strong Bases 
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 However, the intensity, number and position of these bands can be 
influenced by many factors such as number, relative position (meso or $-pyrrolic 
positions) or type of substituting groups that are in the peripheral positions of 
the macrocycle. 
 An NMR spectrum also allows the identification of porphyrins revealing 
the aromatic nature of the macrocycle. Free porphyrins show one signal 
generated by the resonance of the central protons N-H between -2 and -3 ppm 
compared with the signal generated by tetramethylsilane (TMS) protons. This 
phenomenon is due to a strong shield promoted by the electronic current 
around the macrocycle. This same current unprotects the meso and $-pyrrolic 
protons dislocating it resonances to lower fields, at % 7 and 9 ppm [41]. 
 
 
1.4.4 Synthesis of meso–tetra-substituted porphyrins 
 
 meso-Tetra-substituted porphyrins can be obtained in two different ways: 
by modifying a natural porphyrin or by synthesizing de novo from basic units 
(pyrrole and aldehyde). Depending on the intended porphyrin (symmetric or 
asymmetric), a mixture of aldehydes can be used. Aldehyde condensation with 
pyrrole proved to be the main procedure to synthesize meso-substituted 
porphyrins (Scheme 1.2). 
 
 
Scheme 1.2  
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Dada a existência de variadíssimas rotas de síntese de macrociclos tetrapirrólicos,
 
e
consequentemente uma vastíssima bibliografia sobre a síntese deles,
22-25 
vamos de uma
forma breve, apresentar a evolução das rotas de síntese que aplicámos na preparação dos
macrociclos usados neste trabalho.
1.2.1 Síntese de porfirinas meso-substituídas
Algumas das porfirinas meso-substituídas exigem processos de síntese bastante
elaborados,
26,27
 no entanto outras são de síntese fácil, podendo mesmo prepararem-se num
único passo. A partir da condensação de pirrol com um aldeído obtêm-se porfirinas
simétricas (esquema 1.1). No entanto, se na reacção de condensação for usada uma mistura
de aldeídos obtêm-se porfirinas assimétricas. Esta grande versatilidade reaccional permite
a construção de várias porfirinas sem haver necessidade de elaborar rotas de síntese
complexas.
HN
N
N
NH
R
R
R
R
N
H
RCHO+
H
+
Esquema 1.1
1.2.1.1 Síntese de porfirinas meso-tetra-substituídas simétricas
A síntese da meso-tetrametilporfirina foi efectuada pela primeira vez por Rothemund
em 1935. Rothemund preparou mais de trinta porfirinas, entre as quais a
meso-tetrafenilporfirina (TPP) 1.4 (esquema 1.2). O método era bastante simples,
baseando-se no aquecimento de pirrol com os correspondentes aldeídos. A mistura dos
dois reagentes em piridina era aquecida a 220 ºC durante 48 horas, num tubo selado sob
atmosfera de azoto.
2,21,28,29
 Os rendimentos eram, na generalidade, inferiores a 5% e
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 In the last decades, many procedures were used to synthesize these 
compounds allowing the optimization of procedure and improvement of reaction 
yields. Rothemund developed the first method in 1935 when synthesizing, for 
the first time, the meso-tetraphenylporphyrin (TPP) (Scheme 1.3) [43,44]. 
However, this method presented low yields (around 5%) and also produces the 
chlorin form. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.3 
 
 
 Some others methods were presented by different researchers, along the 
years, showing improved yields and solutions for minimizing chlorin formation in 
the reaction. Alder and Longo altered the condensation conditions in order to 
solve the problems that arose with the Rothmund protocol. In this case, the 
reaction occurred in acidic medium and under aerobic conditions. The TPP was 
then achieved by reflux of pyrrole and benzaldehyde in propionic acid for 30 
minutes, rendering the final product in crystalline form directly from the reaction 
medium (Scheme 1.3b). However, the porphyrin macrocycle was equally 
contaminated with the corresponding chlorin, although in smaller quantities [44]. 
 Between 1979 and 1986, Lindsey and his colleagues developed a new 
synthesis methodology based on the fact that the intermediary, the meso-
tetraphenylporphyrinogen is thermodynamically favourable when the pyrrole 
and benzaldehyde are condensed in appropriate conditions (Scheme 1.3c). 
This type of synthesis is performed in two stages: initially the pyrrole and 
aldehyde are condensed in a dry dichloromethane solution, in the presence of 
a: Rothmund conditions: Pyridine, 120°C, 48h 
b: Alder and Longo conditions: CH
3
CH
2
CO
2
H, 141°C, 30 min 
c: Lindsey conditions: CH
2
Cl
2
, r.t., BF
3
, N
2
, 2.DDQ 
d: Rocha Gonçalves conditions: C
6
H
5
NO
2
, CH
3
CO
2
H, 120°C, 1h 
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an acid catalyst (BF3, BCl or TFA), in catalytic amount, at room temperature, 
under nitrogen atmosphere. In a second phase, the formed porphyrinogens are 
oxidized by the addition of an oxidant agent (DDQ or p-chloranil), resulting in 
the corresponding reduced free porphyrin derivatives [45,46]. 
 Rocha Gonsalves and his colleagues proved to be possible to prepare, in 
one step, meso-tetra-arylsubstituted porphyrins in good yields and without their 
chlorin derivatives. Currently, this method is widely used to synthesize meso–
substituted porphyrins and consists in a condensation of pyrrole with 
benzaldehyde, in presence of acetic acid with 30% of nitrobenzene at reflux 
(120 ºC) for 1 hour (Scheme 1.3d) [47]. The acetic acid acts as solvent and 
catalyst, and the nitrobenzene as oxidizing agent. Due to the simplicity of this 
approach, it can be applied to produce a wide range of tetra-substituted 
derivatives comprising four identical aryl units [34]. This method also allows the 
synthesis of asymmetric meso-substituted porphyrins, by condensation of 
pyrrole with a mixture of aldehydes. The proportion of the different compounds 
formed depends on the proportion of aldehydes present in the reaction mixture 
and their reactivity. The following scheme (Scheme 1.4) helps to visualize the 
combination of possible porphyrins, if we consider a mixture of two aldehydes 
(B-CHO and A-CHO) in 1 to 3 eq., respectively, with equal reactivity. 
 
 
 
 
 
Chapter I - Introduction 
 
 14 
 
Scheme 1.4 
 
 
1.4.5 General applications 
 
Currently, porphyrins derivatives have applications in different areas, 
such as catalysis, enzyme catalyzes, models of photosynthetic systems, 
artificial oxygen carriers, chemical sensors, optoelectronic systems, 
semiconductors, superconductors, liquid crystals, biocides agents in PDT and 
aPDT [48,49,50]. 
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1.5 Porphyrins in aPDT – applications 
 
 Although various tumors can be successfully treated with PSs and light, 
the application on the inactivation of microorganisms has not yet found specific 
medical applications and still remains as an open field. Due to their interesting 
physical and chemical properties, porphyrins proved to be good PS for 
antimicrobial photodynamic therapy. During the last years, the application of 
these compounds against several infectious agents has been gaining 
importance, as demonstrated in several in vivo and in vitro studies. As 
mentioned earlier, the major use of aPDT is in the clinical area. Unfortunately, 
due to the dependence on light, this therapy can only be applied on localized 
infections [8]. ALA-based PS showed very good results against herpes simplex 
virus, Trichophyton rubrum and cutaneous leishmaniosis, is tests carried in vivo 
[5,51]. The in vitro tests show that porphyrins can also used as efficient PS for 
bacterial, viral and fungal photoinactivation [7,12,26,52,53,54]. For a porphyrin 
derivative to be used as PS in the inactivation of microorganisms of clinical 
importance, it must fullfill some requirements [8]: 
1. be effective in destroying the disease-causing pathogens; 
2. have selectivity towards the target microorganisms; 
3. minimize the regrowth of pathogens; 
4. be effective against clinical multi-resistant microbial stains  
5. be effective in the presence of biological products. 
 In addition to clinical applications, porphyrins started to be used in 
environmental technology, specifically, in water disinfection, sewage treatment 
plants and in fish-farming plants [27,55,56,57]. The potential for wastewater 
disinfection has been addressed in several studies, with different porphyrins 
and microorganisms (bacteria and bacteriophages) and promising results were 
obtained [55,27,25,58]. In fact, Alves et al. demonstrated an efficient 
inactivation of gram negative and gram positive faecal bacteria with tri- and 
tetracationic porphyrin derivatives, with porphyrins dissolved in the water 
sample or immobilized on solid matrixes [59]. In order to a sustainable use of 
this therapy for environmental applications, some aspects must be considered 
[27,58,59]:  
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1. The possibility to remove de PS after the photodynamic action in order 
to recover/reuse and prevent the release of the PS to the environment; 
2. The stability of PS under the irradiation source and conditions; 
3. The toxicity of the PS in aquatic organisms, having in attention the 
impact of this therapy on the natural non-pathogenic microbial 
communities. 
 
 
1.6 Factors affecting aPDT efficiency 
 
 As mentioned before, aPDT requires three non-toxic elements – light, 
photosensitizer and oxygen – to cause oxidative damage to cells. However, 
some types of cells have ability to repair slight oxidative damage but, if a large 
number of oxidative events takes place within a relatively short period of time, 
the capacity of a cell to recover can be exceeded. For an effective aPDT, the 
oxidative damage must be produced faster than damage repair, making the 
damage to extensive for cell survival. The rate at which damage is produced 
depends upon a number of interacting factors. 
 
 
1.6.1 Light source 
  
 By definition, aPDT requires a light source to provide energy capable of 
inducing the in situ formation, of singlet oxygen, which causes oxidative 
damage to cells. Generally, every visible light source within the appropriate 
wavelength range can be used in aPDT. However, three important factors 
should also be considered: the wavelength(s) of the photoactivating light (light 
source), the fluence rate (irradiation power) and the total dose of light at the 
target site (light dose) influence the aPDT effectiveness [5]. Over the years, a 
variety of light sources (artificial) have been tested for microorganism 
photoinactivation. 
 The light source used in an aPDT approach depends on the wavelength 
that is necessary to activate the PS. This is ultimately determined by the 
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structure and electron absorption spectrum of the PS used [60]. Porphyrin 
derivatives, have a Soret band between 390 – 425 nm and four Q-bands 
between 500 – 650 nm [61]. Therefore, the irradiation light spectrum should 
cover all or a part of the porphyrin absorption spectrum. Several studies show 
that, for the same PS and microorganism, the photodynamic effect varies with 
the light source used [62,63]. As an alternative to artificial light sources, sunlight 
has also been used on aPDT, mainly in environmental approaches 
[23,26,55,62]. Several studies revealed that light source influences the rate and 
the extent of microbial photoinactivation [26,62,64,65]. 
 Light dose, used during irradiation, is also important in the outcome of 
microbial photoinactivation in a fluence rate-time dependent manner [62]. 
According to the law of reciprocity, a certain biological effect is directly 
proportional to the total energy dose, regardless the deliverance regime. 
However, very few studies have addressed the role of the law of reciprocity in 
aPDT [61,66,67]. The studies about the influence of light parameters currently 
available in the literature show that a higher fluence rate over a shorter time 
period may produce different results, in terms of microbial inactivation, from 
those of a low fluence rate over a longer exposure time, corresponding to the 
same light dose [4]. Costa et al. showed that when the same light dose (using 
the same light sources) was obtained under different fluence rates (150; 300; 
600 and 1200 W m-2), the T4-like bacteriophage inactivation was dependent on 
the fluence rate used [62]. 
 
 
1.6.2 Porphyrins as Photosensitizers 
 
 A photosensitizing agent with potentiality in aPDT should be skilled with 
specific features in terms of photophysical and chemical properties. When a 
new porphyrin is synthesized it is expected that it fulfils some photophysical 
requirements such as a high quantum yield for the generation of both the long-
lived triplet state and the cytotoxic singlet oxygen species, a good absorption 
capacity at the wavelength of the spectral region where the light source is 
emitted, a good efficiency to generate ROS and good photostability [11,34]. 
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 A large number of porphyrins have been tested as PSs and a great deal 
of work has been carried out to evaluate the correlation between antimicrobial 
efficiency and the structure of these compounds [1]. Several lines of evidence 
indicate that the nature of the meso-substituted groups, the presence of charge 
and the charge number, and the amphiphilicity of porphyrins have potential 
impact on the efficiency of photosensitization [59,68]. Over the years, many 
porphyrins with different meso-substituted groups were synthesized and tested 
in aPDT. Tricationic porphyrins differing in a meso-aryl group, showed different 
photoinactivation results in gram positive and gram negative bacteria, as well as 
in bacteriophages and viruses of eukaryotes [27,54,59]. Several studies have 
proved that cationic meso-substituted porphyrin derivatives are more efficient in 
the microbial photoinactivation than the neutral or anionic derivatives [27]. Both 
gram negative and gram positive bacteria showed to be more susceptible to 
cationic porphyrins than to neutral and anionic molecules, to which gram 
negative bacteria are usually resistant [4,13,14,8,69]. The existence of an outer 
membrane, which acts as a permeability barrier in gram negative bacteria, 
difficult the entry of the PS [13]. The insertion of positively charged substituents 
in the peripheral position of the tetrapyrrolic macrocycle may largely affect the 
kinetics and extent of binding to the microbial cells [2]. In fact, some 
researchers hypothesized that this phenomenon may be due to the electrostatic 
attraction between the cationic porphyrin derivatives and the negatively charged 
membrane of the microorganisms [70]. Not only the existence of positive 
charges is important, but also the number and the distribution of these charges 
must be taken into consideration. Meso-substituted cationic porphyrins with 
different charge number/distribution (mono-, di-, tri- or tetracationic) have 
already been compared on viral, bacterial, and fungal photoinactivation, with 
very different results [13,27,52,59,56]. Caminos et al., showed that the 
tricationic porphyrin with a trifluoromethyl group (A3B
3+) were more efficient in 
the photoinactivation against Escherichia coli than the tetracationic porphyrin 
(TMAP4+) (Figure 1.7). This can be justified by the presence of a highly lipophilic 
trifluorophenyl group (A3B
3+) that increases the amphiphilic character of the 
porphyrin [12].  
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Figure 1.7 Molecular structures of porphyrins used by Caminos et al [12]. 
 
 
 However, in other studies, dicationic porphyrin derivatives showed to be 
more efficient in the photoinactivation of several bacteria when compared with 
tri- and tetracationic ones [71,72]. Costa et al. obtained results in the 
photoinactivation of a T4-like phage similar to those reported by Caminos et al. 
The photoinactivation was more efficient in the presence of a tricationic 
porphyrin than with tetracationic or dicationic porphyrins [27]. In the case of 
antifungal aPDT, Cormick et al. showed that tricationic porphyrin TFAP3+ 
presented better results than the tetracationic TMAP4+ in the photoinactivation 
of Candida albicans [73] (Figure 1.8). 
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Figure 1.8 Molecular structures of porphyrins used by Cormick et al [73]. 
 
 
Knowing that the lipid bilayer of microbial cell membrane allows the 
passive transport of hydrophobic molecules, several investigation groups 
synthesized hydrophobic PS hoping that the PS diffusion would be facilitated, 
thus improving aPDT results. However, to aPDT assays, PS must be in 
solution, needing for that a hydrophilic character. Therefore, the ideal PS must 
have both hydrophilic and hydrophobic properties, making it amphiphilic. Some 
of the factors that are referred in the literature as increasing the amphiphilic 
character of the porphyrins are the asymmetric charge distribution at the 
peripheral position of the porphyrin, cationic charges combined into different 
patterns with highly lipophilic groups (e.g., trifluoromethyl groups), the 
introduction of aromatic hydrocarbon side groups and the modulation of the 
number of positive charges on the PS [72,74,75,76,77,78]. This increases the 
amphiphilic character of the PS and seems to enhance its affinity for bacteria, 
which ultimately improves its accumulation in the cells and is accompanied by 
an increase in the photoinactivation efficiency [72,74,79,77]. 
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1.6.3 Mechanism of photosensitization: the role of the oxygen 
 
 The initiating step of the photosensitizing mechanism is the absorption of a 
light photon by the sensitizer, causing a promotion of the PS to the extremely 
unstable excited singlet state (S1
*) (Figure 1.9). In this state, the PS has a very 
short lifetime, in range of 10-6-10-9 seconds [4]. The excited PS can change to a 
lower energy state, ground sate (S0), by fluorescence (radiative process) or by 
internal conversion with energy being lost as heat (thermal process). Instead, 
(S1
*) may be produced by intersystem conversion to the longer lived (10-3 s) 
excited triplet state (T*1). Once in the triplet state, PS can react according to two 
types of photooxidative reactions, known as type I and type II mechanisms. 
 
 
 
Figure 1.9 Modified Jablonski diagram. 
 
Type I pathway involves an hydrogen or electron-transfer reaction (e-) 
from T*1 with the intervention of a substrate, to produce radical ions that can 
react with molecular oxygen (O2) to produce cytotoxic species, such as 
superoxide, hydroxyl and lipid-derived radicals, which initiate free radical chain 
reactions. Type II mechanism is mediated by energy transfer process from T*1 
to ground state molecular oxygen (3O2) to produce excited-state singlet oxygen 
(1O2) [1,70,80]. This reactive cytotoxic specie (
1O2) can oxidize many biological 
molecules, such as proteins, nucleic acids and lipids. Due to high reactivity, 
singlet oxygen has a short lifetime and a limited diffusion in the cellular 
advantage of dual selectivity in that the PS can be targeted to its
destination cell or tissue, and in addition the illumination can be
spatially directed to the lesion. PDT was originally discovered
over a hundred years ago by its light-mediated killing effect on
microorganisms5 but since then has been principally developed as
a treatment for cancer6 and age-related macular degeneration.7
PDT has recently attracted attention as a possible alternative
treatment for localized infections.8-10 It is proposed that for
antimicrobial PDT the PS would be topically or locally applied to
the infected tissue and, after a relatively short time interval, light
would be delivered to the area and depending on the effectiveness
of the antimicrobial PS, up to 3 logs of bacterial or fungal cells
would be killed without causing unacceptable damage to the host
tissue. A 3-log reduction is accepted as an effective antimicrobial
intervention equivalent to disinfectants.11 It has been reported that
photodynamic inactivation (PDI) is as effective12 (or even more
effective13) against multidrug-resistant bacteria as it was against
naive species, andmoreover, the PDI treatment itself is considered
to be unlikely to cause bacterial resistance to damage by ROS.14
This is because the PDI insult is relatively brief (many logs killed
over minutes) as compared with antibiotics that are typically
present for many days or weeks, and because the type of damage
to biomolecules done by PDT is relatively nonspecific compared
with antibiotics that in general specifically inhibit a target enzyme.
It is known that gram-negative bacteria are resistant to PDIwith
many commonly used PSs that will readily lead to phototoxicity
for gram-positive species,15 and that PSs bearing a cationic
charge16 or agents that increase the permeability of the outer
membrane will increase the efficacy of killing of gram-negative
organisms.17 The ideal PS for killing bacteria should possess an
overall cationic charge and preferably multiple cationic charges.18
Buckminsterfullerenes (BFs) are closed-cage molecules entirely
composed of sp2-hybridized carbon atoms. The presence of many
conjugated double bonds gives these molecules a high optical
absorption in visible wavelengths and a high triplet yield from the
excited-singlet state.19 The triplet state of the fullerene molecule can
interactwithmolecular oxygenvia two reactionpathways (Figure 1).
First, energy transfer can take place between the fullerene triplet and
ground-state triplet oxygen, giving the reactive species singlet
oxygen (type II pathway) and the ground-state fullerene. Second,
either the triplet fullerene (or possible the excited-singlet fullerene)
can accept an electron from a biological reducing agent such as
nicotinamide adenine dinucleotide, reduced form, to give the
fullerene radical anion. This species can then transfer an electron to
molecular oxygen to form superoxide radical anion, thus restoring
the fullerene ground state. Superoxide anion can subsequently give
rise to hydrogen peroxide and the highly reactive hydroxyl radical.20
Although pristine C60 in the form of nanoaggregates21 or
cyclodextrin complexes22 is able to produceROSupon illumination,
the process is more efficient in biological media when the fullerenes
have been chemically derivatized to make them water soluble. We
have already shown that fullerenes derivatized with one or more
cationic charges via quaternary ammonium groups efficiently bind
and penetrate all classes ofmicrobial cells and therefore act as broad-
spectrum light-activated antimicrobials.23 In this report we describe
the preparation and testing of new functionalized fullerene
derivatives with cationic charges as broad-spectrum antimicrobial
PSs against a panel of human pathogens.
Methods
Fullerene synthesis and characterization
The compounds were characterized by 1H and 13C nuc ear
magnetic resonance (NMR), 500 MHz (Innova500 spectrome-
ter, Varian Inc., Palo Alto, California), Fourier transform–
infrared (spectroscopy) (ATR-FT-IR, PerkinElmer, Waltham,
Massachusetts), and matrix-assisted laser desorption ionization–
time-of-flight mass spectrometry (MALDI-TOF).
BF1
C60 (100 mg, 0.14 mmol) was dissolved in 150 mL toluene.
Sarcosine (30.82 mg, 0.35 mmol) and 4-pyridinecarboxaldehyde
(46 μL, 0.59 mmol) were added, and the reaction mixture was
refluxed for 48 hours. The toluene was removed and the product
dried overnight in vacuo. The product was purified on a silica gel
column using a solvent ratio of 1000:1:1 of toluene, triethylami e,
and ethyl acetate, respectively. MALDI-TOF (mass spectrome-
try) calculated for C68H10N2 854.8, found 853.2 [M – H]
–. The
brown powder was treated with a large excess of iodomethane at
ambient temperature (22–25°C) for 48 hours. The material was
collected by filtration and washed with methanol.
Electro-spray ionization mass spectrometry (ESI-MS) calcu-
lated for C69H13N2 869.4 [M]
+, found 869.1:
1H NMR DMSO − d6; TMS ref :ð Þ d = 2:759 3H ; sð Þ;
4:352 3H ; sð Þ; 4:437 1H ; dð Þ; 5:161 1H ; dð Þ;
5:553 1H ; sð Þ; 8:593 2H ; dð Þ; 9:047 2H ; dð Þ
13C NMR DMSO − d6; TMS ref :ð Þ d = 48:48; 69:09; 69:93;
76:53; 79:84; 126:0; 128:2; 128:9; 129:6; 136:0; 136:2;
137:0; 138:0; 139:6; 140:1; 140:3; 140:4; 141:8; 141:9;
143:3; 144:5; 144:7; 145:0; 145:3; 145:5; 145:6; 145:7;
145:8; 145:9; 146:1; 146:3; 146:5; 146:8; 147:4; 147:5;
151:8; 152:7; 154:3; 156:2; 156:6:
FT# IR m cm−1! " : 2919; 1454; 1210; 1006; 739; 520
LogKOW = − 1:331
where DMSO is dimethylsulfoxide.
Figure 1. Schematic illustration of fullerene-mediated photodynamic therapy
including the Jablonski diagram and the formation of type I and type II
reactive oxygen species (ROS).
443L. Huang et al / Nanomedicine: Nanotechnology, Biology, and Medicine 6 (2010) 442–452
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environment, restricting its action to a 0.1 µm distances.  
After the photoprocess, the PS is not necessarily destroyed and can 
return to ground state by dissipating energy by heat or by phosphorescence, 
without chemical alteration. This allows the PS to remain active and repeat the 
process of energy transference several times [80]. It can act as a kind of 
catalyst and many molecules of singlet oxygen can be formed from a single 
molecule of PS, as long as light and molecular oxygen are present [11]. 
 The photodynamic activity to induce cell damage or death is determined 
by five important photophysical/photochemical parameters [81]: 
1. an overall lipophilicity and ionization of the photoactive dyes; 
2. the molecular extinction coefficient &; 
3. the quantum yield of the triplet state formation 'T; 
4. the redox potential of the excited states (singlet and triplet) of the 
PS, if the reaction follows the type I pathway, 
5. the quantum yield of the 1O2 generation, if the reaction occurs by 
a type II photosensitization. 
 
 
1.7 Thesis outline 
 
 The main goal of this work was to synthesize new glycosilated porphyrins 
from known porphyrin derivatives, and to evaluate their photodynamic effect on 
two environmental gram positive bacterial strains, known to have different 
sensitivity to oxidative stress caused by UV: Brevibacterium sp. (susceptible). 
and Micrococcus sp. (resistant). Is also an aim to compare the susceptibility 
level of lipid and protein peroxidation during aPDT to previous UV results. 
The obtained results are presented in this master dissertation, which is 
organized in four chapters: 
 Chapter I consists on a broad introduction, focusing on the antimicrobial 
photodynamic therapy and on the porphyrin derivatives as photosensitizers in 
antimicrobial photodynamic therapy. 
 Chapter II describes the synthesis and application of galactoporphyrinic 
derivatives, the approaches followed to synthesize the porphyrins and to 
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characterize them mainly by NMR and mass spectrometry technics. 
 Chapter III describes the kinetics of photodynamic inactivation of two 
cationic porphyrins, described in the previous chapter. The results of the 
photophysical studies (photostability and singlet oxygen production) performed 
in conditions similar to those used in the aPDT assays are also presented. The 
assessment of lipid and protein peroxidation as descriptors of cell damage are 
presented and discussed in an attempt to identify the molecular targets of the 
tested porphyrins. 
Chapter IV presents the main conclusions. 
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2.1 Glycoporphyrins – Overview 
 
 Carbohydrates are the most abundant class of organic compounds found 
in living organisms and nature, playing vital roles [82,83]. The conjugation of 
carbohydrate molecules with porphyrins can improve water solubility, ideal 
hydrophilic/hydrophobic ratios and higher membrane recognition and 
permeability [84]. In fact, the amphiphilic character of these compounds enables 
them to better permeate into both lipophilic and hydrophilic biological structures 
[85]. These compounds present several applications, mainly as PS in PDT and 
aPDT, as drug sensors, catalysis, among others [86,87,88]. 
 Currently, two approaches for the synthesis of glycoporphyrins have 
been described: the direct glycosylation of adequate functionalized porphyrins, 
obtained from natural or synthetic sources, and the chemical synthesis from 
adequate syntons already fulfilling the glycoconjugate requirement. The first 
strategy, direct glycosilation of porphyrins, allows the variation of the structure 
and number of carbohydrate moieties and, thus, controls the amphiphilic 
character of the final product [89]. The second approach considers the acid-
catalysed condensation of pyrrole with an aldehyde or a mixture of aldehydes or 
still with dipyrrylmethane–aldehyde mixture allowing the tuning of the 
hydrophilic-hydrophobic balance. Condensation of glycosylated benzaldehydes 
with pyrrole can take place in boiling acetic acid or under Lindsey conditions 
[85]. 
 Many glycoporphyrins were already been synthesized using one or the 
other strategy and, in many cases, the porphyrin derivatives were linked to the 
sugar moiety by ester, amide, ether, thioether and amine functionalities 
[90,91,92]. Despite the scarce information of thioether compounds, it is 
important to highlight the characteristics that distinguish these compounds to 
their ester and ether analogues [89,93]. The stability of the S-glycosyl bonds to 
hydrolysis suggests that these thioglycosylated porphyrins could exhibit higher 
activity in several application, namely in PDT [94]. 
 Important features of glycoporphyrins are also related to the porphyrin 
template chosen. Several meso-arylporphyrins were used as template [95]. 
However, the saccharide-porphyrin conjugates containing TPPF20 as core 
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platform displays great triplet quantum yields, which results in greater yields of 
singlet oxygen [96,97]. This feature has led to the extensive use of TPPF20 as 
scaffold to make a variety of tetrakis(thioglycosyl)porphyrin derivatives, for 
diverse applications [98,99,100].  
 Also, previous studies show that the combination of groups with positive 
charges with carbohydrate units can enhance water solubility, biological 
recognition and membrane permeability. Based on this assumption, various 
cationic glycoporphyrins have been synthesized [98,99,101,102]. The most 
commonly approach for the synthesis of cationic porphyrins is the alkylation of 
pyridyl substituent groups. These cationic glycoporphyrins can be synthesized 
in both methods described above, by the condensation of pyrrole with proper 
pyridinecarboxaldehyde and glycobenzaldehyde derivatives or by coupling an 
adequate sugar derivative to a pyridylporphyrin. Note that in all cases 
appropriate sugar protecting groups, which allow an easy purification of the 
glycoporphyrinic derivative during the synthesis and an easier characterization, 
can be readily cleaved later. 
 
 
 
 
 
 
 
Figure 2.1 Some glycoporphyrins derivatives already synthesized. 
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N
NH N
HN
N
CH3
CH3
Sugar
(37 !C, 5% CO2). Five hundred microliters of 1.0 lM photosensi-
tizer (chlorin 2 and S-glycosylated chlorins 2a and 2b) in DMEM
containing 10% FCS and 2% DMSO was added to each well, and
then incubation was continued for 24 h in the presence of the
photosensitizers. The final concentration of photosensitizers was
0.5 lM (1% DMSO). The cells in one 24-well plate were washed
twice with 500 lL of PBS, and 500 lL of Hank’s balanced salt
solution (HBSS) was added to each well. Fluorescence images of
photosensitizers in cells were taken with the CLSM using an exci-
tation wavelength of 543 nm (He-Ne laser). For the other plate,
on the other hand, 500 lL of DMEM containing 10% FCS was
added to each well instead of HBSS. Then each well was photoir-
radiated under the same conditions as described in the previous
section. Three hours after photoirradiation, the cells were stained
with DAPI 0.3 lM PBS for 5 min at room temperature, and then
washed twice with 500 lL of PBS, and finally 500 lL of HBSS
was added. Fluorescence images of DAPI-stained cells were taken
using an excitation wavelength of 364 nm.
Scheme 1. Synthesis of S-glycosylated porphyrins and chlorins.
26 S. Hirohara et al. / Journal of Photochemistry and Photobiology B: Biology 97 (2009) 22–33
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2.2 Experimental Procedures 
 
Reagents, solvents and equipment. 
 
• The commercial reagents, of different brands, were used without any 
prior purification. 
• The solvents used in the transformations were  P.A. grade 
• The evolution of some reactions was followed by TLC, using small plastic 
sheets coated with silica gel 60 (Merck). 
• The NMR spectra were recorded on a Bruker AMX 300 apparatus. 
Deuterated solvents were used, and TMS (' = 0 ppm) was used as 
internal standard. 
• Mass spectra were performed with a spectrometer-MALDI TOF/TOF 
Applied Biosystems 4800 using adequate solvents and matrixes. 
• The ultraviolet-visible spectrum was recorded on a Shimadzu 
spectrophotometer UV-2501PC. 
• The irradiation system used to determine the production of 1O2, was a 
Lumacare source, model LC-122, consisting on a 250 W halogen lamp 
coupled to a optic fibre beam of white light (400-800 nm). The light was 
filtered using a cut-off filter for wavelengths <540 (orange filter). The 
radiation power was measured with a potentiometer bright Spectra 
Physics, model 407A and the sensor of the same brand, model 407A-2. 
 
 
meso-Tetrakis(pentafluorophenyl)porphyrin (1). Pentafluorobenzaldehyde (4 
mL, 32 mmol) was added to a refluxing mixture of glacial acetic acid (200 mL) 
and nitrobenzene (150 mL). Pyrrole (2.5 mL, 36.01 mmol) was then added 
dropwise over 15 min and the mixture was refluxed for 1 h. After cooling, the 
acetic acid and nitrobenzene were distilled to dryness under reduced pressure. 
The crude material was collected in chloroform and submitted to column 
chromatography (silica gel) using a mixture of chloroform–petroleum ether (1:1) 
as eluent. After evaporation of the solvent, the desired porphyrin 1 was 
recrystallized from methanol (1.0 g, 11.4% yield). 1H NMR: ' -2.93 (s, 2H, NH), 
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8.92 (s, 8H, ß-H). 19F NMR ': -160.1 to -160.0 (m, 8F, Ar-o-F), -174.7 (t, 4F, Ar-
p-F); -184.9 to -184.7 (m, 8F, Ar-m-F). MALDI-MS m/z: 975 (M+H)+. 
 
 
5,10,15,20-Tetrakis[2,3,5,6-tetrafluoro-4-(4-pyridylsulfanyl)phenyl] 
porphyrin (2). 4-Mercaptopyridine (47 mg, 4.1 eq.) and diethylamine (1 mL) 
were added to a solution of meso-tetrakis(pentafluorophenyl)porphyrin, TPPF20, 
(100 mg; 0.1 mmol) in dry dimethylformamide (5 mL). This mixture was kept 
under stirring for 1h, under a nitrogen atmosphere, at room temperature. After 
evaporation of the DMF, under reduced pressure, the residue was subjected to 
flash chromatography using dichloromethane and 2% methanol in 
dichloromethane as eluents. The fraction containing porphyrin 2 (120 mg, 90%) 
was concentrated and the porphyrin was crystallized from (98:2) 
dichloromethane:methanol/hexane. 1H NMR: ' -3.08 (s, 2H, NH), 7.73 (d, J= 
5.0 Hz, 8H, Ar-o-H), 8.64 (d, J= 5.0 Hz, 8H, Ar-m-H), 9.59 (s, 8H, $-H). 19F 
NMR: ' -160.95 (dd, J= 11.3 and 25.4 Hz, 8F, Ar-o-F), -156.04 (dd, J= 11.3 and 
25.4 Hz, 8F, Ar-m-F). MALDI-MS m/z: 1339.0 (M+H)+. 
 
 
6-iodo-1,2:3,4-Di-O-isopropylidene-!-D-galactopyranose (S1). Imidazol 
(420 mg, 6.17 mmol) and triphenylphosphine (1.63 g, 6.21 mmol) were added 
to a solution of 1,2:3,4-Di-O-isopropylidene-%-D-galactose (540 mg, 2.07 mmol) 
in tetrahydrofuran (50 mL) and iodine (1.05 g, 4.14 mmol) was further added in 
small pieces. The reaction was conducted overnight at room temperature under 
stirring and nitrogen atmosphere. The reaction was treated with a saturated 
solution of NaHCO3 (50 mL), and excess of iodine was treated with a small 
amount of Na2S2O3. The reaction mixture was extracted with dichloromethane 
and the organic phase dried with anhydride sodium sulphate. After 
concentration, the residue was subjected to flash chromatography using 
toluene/ethyl acetate (90:10) as eluents. The fraction containing the sugar S1 
(689.3 mg, 90%) was concentrated, forming initially an oil which crystallized 
after cooling and drying. 1H RMN: ' 1.34, 1.36, 1.45 e 1.55 (4s, 12H, 4x CH3); 
3.18-3.35 (m, 2H, H-6); 3.95 (td, 1H, J=1.7, 6.9 and 7.0 Hz, H-5); 4.31 (dd, 1H, 
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J=2.5 e 5.0 Hz, H-2); 4.41 (dd, 1H, J=1.8 e 7.5 Hz, H-4); 4.62 (dd, 1H, J=2.5 e 
8.1 Hz, H-3); 5.55 (d, 1H, J=5.0 Hz, H-1) MALDI-MS m/z: 371.0 (M+H)+. 
 
 
5-[2,3,5,6-tetrafluoro-4-[N-(isopropylidene-6-deoxy-galactopyranos-6-
yl)pyridinium-4-ylsulfanyl]phenyl]-10,15,20-tris[2,3,5,6-tetrafluoro-4-(4-
pyridylsulfanyl)phenyl]porphyrin mono-iodide (11). Sugar S1 (33 mg, 89.2 
µmol, 2 equiv) was added to a solution of porphyrin 2 (60 mg, 44.8 µmol) in 
diglyme (1mL). The reaction mixture was stirred for 4 h at reflux (162 ºC) in the 
dark and under nitrogen atmosphere. After cooling at room temperature, 
compound 11 was purified by column chromatography (silica gel) using 
dichloromethane / methanol (90:10) as eluent. Porphyrin 11 was crystallized 
from petroleum ether/dichloromethane/methanol (14.2 mg, 8% yield). 1H NMR: 
% -2.84 (s, 2H, NH), 1.30, 1.34, 1.43. 1.44 (4s, 12H, CH3), 4.34 (d, J= 7.8 Hz, 
2H, Gal-H), 4.69 (s, 2H, Gal-H), 4.75 to 4.83 (m, 1H, Gal-H), 5.37 and 5.42 (2d, 
J= 2.4 and 1.6 Hz, 1H, Gal-H), 5.52 (d, J= 4.8 Hz, 1H, Gal-H), 7.35-7.37 (m, 6H, 
10,15,20-Ar-o-H), 8.01 (d, 2H, J= 7.0 Hz, 5-Ar-o-H), 8.64-8.67 (m, 6H, 10,15,20-
Ar-m-H), 9.01-9.09 (m, 6H, $-H), 9.21 (s, 2H, $-H), 9.36 (d, J= 7.1, 2H, 5-Ar-m-
H). 19F NMR: -158.3 to -158.1 (m, 6F, 10,15,20-Ar-o-F), -155.4 to -155.3 (m, 2F, 
5-Ar-o-F), -154.3 to 154.1 (m, 6F, 10,15,20-Ar-m-F), -153.1 to -153.0 (m, 2F, 5-
Ar-m-F). MALDI-MS m/z: 1581.1 (M)+. 
 
 
5-[N-(Isopropylidene-6-deoxy-galactopyranos-6-yl)pyridinium-4-yl]-
10,15,20-tris(4-pyridyl)porphyrin mono-iodide (12). Sugar S1 (60 mg, 0.1 
mmol, 1 equiv) was added to a solution of porphyrin 5 (70 mg, 0.1 mmol) in 
diglyme (1mL). The reaction mixture was stirred for 2 h at reflux (162 ºC) in the 
dark and under nitrogen atmosphere. After cooling at room temperature, 
compound 11 was purified by column chromatography (silica gel) using 
dichloromethane / methanol (90:10) as eluent. Porphyrin 12 was crystallized 
from petroleum ether/dichloromethane/methanol (43 mg, 50% yield). 1H NMR: % 
-3.04 (s, 2H, NH), 1.36, 1.44, 1.54 and 1.55 (4s, 12H, CH3), 4.42 (d, J=9.9 Hz, 
1H, Gal-H), 4.55 (dd, J=2.5 and 6.0 Hz, 1H, Gal-H), 4.63 (d, J=9.2 Hz, 1H, Gal-
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H), 4.86 (dd, J=2.4 and 6.0 Hz, 1H, Gal-H), 5.00 (dd, J= 9.3 and 12 Hz, 1H, Gal-
H), 5.31 (d, J=12.0 Hz, 1H, Gal-H), 5.64 (d, J= 4.8 Hz, 1H, Gal-H1), 8.28 (dd, 
J=1.6 and 6.0 Hz, 6H, 10,15,20-Py-o-H), 8.89-8.94 and 9.05-9.13 (2m, 16H, 5-
Py-o-H, 10,15,20-Py-m-H and $-H) and 9.59 (d, J= 6.7 Hz, 2H, 5-Py-m-H). 
MALDI-MS m/z: 861.3 (M+). 
 
 
5-[N-(Isopropylidene-6-deoxy-galactopyranos-6-yl)pyridinium-4-yl]-
10,15,20-tris(N-methylpyridinium-4-yl)porphyrin tetra-iodide (13). A large 
excess of iodomethane (1 mL, 15.5 mmol) was added to a suspension of 
compound 12 (30 mg, 34.1 !mol) in dry DMF (5 mL). The reaction mixture was 
maintained under stirring for 5 h at 40 ºC, in a closed vase. After this period, the 
mixture was cooled and the product precipitated with diethyl ether. The 
precipitate was filtered, and washed with diethyl ether. The solid phase was 
then dissolved in acetone/water (1:1) and, after concentration, re-precipitated 
from water/acetone. The methylated product was filtered, washed with acetone 
and dried under vacuum, to yield a brown-reddish powder (27.8 mg, 90%). 1H 
NMR: % -3.10 (s, 2H, NH), 1.37, 1.45, 1.54, 1.55 (4s, 12H, 4x CH3), 4.44 (d, 
J=8.9 Hz, 1H, Gal-H), 4.57 (dd, J=2.4 and 6.0 Hz, 1H, Gal-H), 4.68 (d, J=4.8, 
1H, Gal-H), 4.73 (s, 1x CH3), 4.88 (dd, J=2.1 and 9.0 Hz, 1H, Gal-H), 4.99 to 
5.07 (m, 1H, Gal-H), 5.36 (d, J=11.7 Hz, 1H, Gal-H), 5.65 (d, J= 4.8 Hz, 1H, 
Gal-H), 9.00 and 9.11 (2d, J=6.1 and 6.7 Hz, 10H, $-H and 5-Ar-o-H), 9.22 (s, 
6H, 10,15,20-Ar-o-H), 9.49 and 9.62 (2d, J=6.5, 8H, Ar-m-H). MALDI-MS m/z: 
907.4 (M+H)+. 
 
 
5,10,15,20-Tetrakis(N-methylpyridinium-4-yl)porphyrin tetra-iodide (14). A 
large excess of iodomethane (4 mL, 64.3 mmol) was added to a suspension of 
5,10,15,20-tetrakis(4-pyridil)porphyrin (100 mg, 162 !mol) in dry DMF (20 mL). 
The reaction mixture was maintained under stirring for 5 h at 40 ºC, in a closed 
vase. After this period, the mixture was cooled and the product precipitated with 
diethyl ether. The precipitate was filtered, and washed with diethyl ether. The 
solid phase was then retaken in acetone/water (1:1) and, after concentration, 
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re-precipitated from water/acetone. The methylated product was filtered, 
washed with acetone and dried under vacuum, to yield a brown-reddish powder 
(180 mg, 94%). 1H NMR: ' -3.12 (s, 2H, NH), 4.73 (s, 12H, CH3), 9.00 (d, J= 
6.5, 8H, Ar-o-H), 9.22 (s, 8H, $-H), 9.49 (d, J= 6.5, 8H, Ar-m-H). ESI-MS m/z: 
169.6 (M4+), 226.1 (M3+). 
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2.3 Initial working plan 
 
 Considering that, for the use of a PS in aPDT, the porphyrin should have 
an amphiphilic character, the objective was set the synthesis of 
galactoporphyrins. The initial work plan, in respect to the synthesis of new 
porphyrin derivatives, was designed to obtain four novel galactoporphyrins with 
four galactose units each, two with protected sugar units (3 and 6) and two 
others with unprotected sugar moieties (4 and 7) (Schemes 2.1 and 2.2). For 
that, two well-known porphyrins were used as template, 5,10,15,20-
tetrakis[2,3,5,6-tetrafluoro-4-(4-pyridylsulfanyl)phenyl]porphyrin 2 and 
5,10,15,20-tetrakis(4-pyridil)porphyrin 5. A secondary objective was the 
methylation of the porphyrin templates in order to purchase the differences 
between the cationic galactoporphyrins and cationic porphyrins through 
photophysical and aPDT studies. 
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Scheme 2.1 
 
Scheme 2.2 
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2.4 Synthesis of template compounds used for biological studies 
 
 This first subchapter describes the synthesis of the porphyrins used as 
template to prepare the desired compounds. For that, and in order to further 
couple the carbohydrate units, some meso-tetra-substituted porphyrinic 
macrocycles with appropriate functional groups were synthesized. 
 
 
2.4.1 Synthesis of 5,10,15,20-Tetrakis(pentafluorophenyl)porphyrin 
(TPPF20) 
 
The 5,10,15,20-tetrakis(pentafluorophenyl)porphyrin (1) was prepared by 
the condensation of the pyrrol with pentafluorobenzaldehyde (1:1) (Scheme 
2.3). The condensation was carried out in a mixture of acetic acid/nitrobenzene, 
at reflux (120 ºC), during two hours. After the reaction, the solvents were 
distilled, under reduced pressure, until dryness. Subsequently, the crude 
reaction was taken into chloroform and subjected to a rapid column 
chromatography (silica gel), using chloroform/petroleum ether (1:3) as eluente. 
The first fraction was identified, by thin layer chromatography (TLC), as being 
porphyrin 1 with 11.4% yield. 
 
Scheme 2.3 
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Compound 1 was characterized by 1H and 19F NMR and mass 
spectrometry, MALDI-MS. The 1H NMR is very simple showing only two signals 
in the shape of singlets, characteristic of a symmetric structure. One of the 
signals appears at % 8.92 ppm, chemical deviation characteristic of aromatic 
protons, corresponding to the eight $-pyrrolic protons that due to the ring 
current are unprotected. The other singlet appears at % -2.93 ppm created by 
the resonance of the two NH protons. These protons are more protected than 
the TMS ones (0 ppm), appearing at negative chemical deviation. In the 19F 
NMR three signals were observed, one triplet and two multiplets. The triplet sign 
appears at % -174.7 ppm, corresponding to the four fluor atoms at the para 
positions. The multiplicity of this signal is due to the coupling with the two meta–
F atoms. The two multiplet signals correspond to eight fluor atoms each, 
observed between % -160.1 to -160.0 and -184.9 to -184.7, being identified as 
the fluor atoms at the ortho and meta positions, respectively. The mass 
spectrum presents one pick m/z 975 corresponding to the molecular ion (M+H)+ 
of 1. 
 
 
2.4.2 Synthesis of 5,10,15,20-Tetrakis[2,3,5,6-tetrafluor-4-(4-
pyridylsulfanyl)phenyl]porphyrin (2) 
 
The 5,10,15,20-tetrakis[2,3,5,6-tetrafluor-4-(4-pyridylsulfanyl)phenyl] 
porphyrin (2) was prepared by the reaction of porphyrin 1 with 4-
mercaptopyridine (8). The reaction was conducted in dimethylformamide (DMF) 
in presence of triethylamine (Et3N), during one hour at room temperature and 
under nitrogen atmosphere. After solvent evaporation, the crude material was 
collected in chloroform/methanol (95:5) and submitted to column 
chromatography (silica gel) using a mixture of chloroform/methanol (95:5) as 
eluent. The fourth fraction was identified, as being porphyrin 2, obtained in 80% 
yield. 
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Scheme 2.4  
 
 
Compound 2 was characterized by 1H and 19F NMR and mass 
spectrometry, MALDI-MS. The 1H NMR shows two singlets at % -3.08 and 9.59, 
like porphyrin 1, and two doublets, at % 7.73 (J= 5.0 Hz) and 8.64 ppm (J= 5.0 
Hz), corresponding to eight ortho and eight meta pyridyl protons, respectively. 
The first signal is related to the resonance of the NH protons and the last one, 
at lower field, is related to the eight $-pyrrolic protons. The 19F NMR spectrum 
of porphyrin 2 confirmed the substitution of the four para-fluorine atoms by the 
mercaptopyridine, by the disappearance of the signal corresponding to the 
resonances of all four para-fluorine atoms. The resonances of the ortho- and 
meta-fluorine atoms appear as two double doublets (J= 11.3 and 25.4 Hz) at ' -
160.95 and -156.04 ppm, respectively. The mass spectrum also confirms this 
compound with the presence of one pick at m/z 1339.0 (M+H)+. 
 
 
2.4.3 Synthesis of 6-iodo-1,2:3,4-Di-O-isopropylidene-!-D-
galactopyranose 
 
6-iodo-1,2:3,4-Di-O-isopropylidene-!-D-galactopyranose (S1) was 
obtained by the addition of iodide to a solution of 1,2:3,4-Di-O-isopropylidene-%-
D-galactopyranose, imidazol and triphenylphosphine in tetrahydrofuran (THF) 
(Scheme 2.5). The reaction was conducted for approximately one day, at room 
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temperature, under nitrogen atmosphere. A saturated solution of NaHCO3 was 
then added in order to neutralize the reaction mixture. The excess of iodide was 
treated with a little portion of Na2S2O3, and the organic phase was extracted 
with dichloromethane and dried with anhydride sodium sulphate. The mixture 
was concentrated and collected in toluene and submitted to column 
chromatography (silica gel) using a mixture of ethyl acetate/toluene (90:10) as 
eluente. The second fraction was identified, by TLC, as being the compound 
S1, with 90% yield. 
 
Scheme 2.5 
 
 
Compound S1 was characterized by 1H NMR spectroscopy and mass 
spectrometry, MALDI-MS. In the 1H NMR four signals appear in the form of 
singlet, corresponding to the resonance of four methyl groups of isopropylidene 
at % 1.34, 1.36, 1.45 and 1.55 ppm. The duplet at % 5.55 ppm (J= 5.0 Hz) 
corresponds to the resonance of the anomeric proton (H-1). The other proton 
resonances appear in between those to signals in different multiplicities. . Mass 
spectrometry also confirmed compound S1 with the presence of a peak at m/z 
371.0 corresponding to the molecular ion (M+H)+. 
 
 
2.5 Synthesis of galactoporphyrins 
 
2.5.1 Coupling of 5,10,15,20-tetrakis[2,3,5,6-tetrafluor-4-(4-
phyridylsulfanyl)phenyl]porphyrin to galactose iodide derivative 
 
The objective of this task was to synthesize a tetragalactoporphyrin 
derivative 3 having as base porphyrin 2 and the sugar S1 (Scheme 2.1). In 
order to obtain compound 3 the sugar was directly added to porphyrin 2 or, as a 
O
O
O
O
O
I
O
O
O
O
O
OH
I2, Toluene
Reflux
S1
Chapter II – Synthesis of galactoporphyrin derivatives 
 40 
different approach, the sugar was added to 4-mercaptopyridine (8) and this 
compound was coupled to porphyrin 1. The second procedure was found to be 
the most convenient approach and was used in the subsequent assays, 
however without success until now.  
 
 
Fist way 
 
Compound 8 has two reactive positions (N and S). The S–position was 
initially protected with the intention of linking the sugar moiety to the N position 
(Scheme 2.6). The different strategies attempted to protect the S–position are 
summarized in Table 2.1. All experiments were conducted at room temperature 
but none was successful. 
 
Scheme 2.6 
 
Table 2.1 Reaction conditions used to attempt compound 9. 
 
In the first conditions (reaction 1), compound 8 was dissolved in dry 
dichloromethane. The solution was treated with acetic anhydride and 
triethylamine, and leave under nitrogen. After one hour, at room temperature, 
the reaction was finished. After that, the reaction mixture was washed with an 
aqueous solution of NaHCO3 and extracted with chloroform. The organic phase 
was dried with anhydride sodium sulphate (Na2SO4), the solvent removed, and 
then separated by preparative TLC plates, using a mixture of toluene/ethyl 
Reaction Solvent Base Protective Agent Reaction time 
1 Dry CH2Cl2 Et3N Acetic anhydride 1h 
2 Acetone Et3N 
Acetyl chloride 1h 
3 Acetone 
Potassium 
carbonate 
Acetyl chloride 1h 
NHS NAcS
8 9
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acetate (4:1) as eluente. Two new compounds, less polar than compound 8, 
were obtained and characterized by 1H NMR. Through 1H NMR we concluded 
that the compound more polar were 4-(4-pyridinyldisulfanyl)pyridine (10a, 
Figure 2.2), explained by the oxidation in basic conditions of the thiols to 
disulphide. The other compound purified seems to be the salt of the initial 
compound 8 (10b). 
 
Figure 2.2 Compounds obtained during the reaction 1, 2 and 3. 
 
Two more reactions were attempted. The methods 2 and 3 differ from 
each other in the base used. In reaction 2 was used triethylamine as base 
(Et3N) and in reaction 3 was used potassium carbonate. The addition of a base 
caused some change in the colour of the product, which was originally yellow. 
With the use of Et3N, the reaction resulted initially in an orange product, 
gradually changing to a less intense colour. With potassium carbonate, the 
reaction product was white with no major changes in colour during the reaction. 
Both methods produced also variable amounts of compound 10a, but in a much 
lesser degree than in the reaction 1, due to the use of nitrogen that prevents the 
interference of the oxygen in the reaction.  
 
 
Direct alkylation of porphyrin 2 
 
The coupling of four galactose units directly to porphyrin 2 (Scheme 2.7) 
was also attempted. For this, the reaction was conducted in diglyme at reflux, 
during four hours under nitrogen atmosphere. The reaction mixture was 
precipitated in n-hexane in order to remove the reaction solvent. The precipitate 
was filtered through cotton in a funnel, washed with n-hexane and collected in 
chloroform/methanol (95:5). The final solution was concentrated and submitted 
to a column chromatography (silica gel) using chloroform/methanol (90:10) as 
NSN S
10 a
NS
10 b
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eluent. Two new fractions were collected. Mass spectrometry and 1H NMR 
identified one compound as compound 11, that presented only one 
carbohydrate moiety coupled to compound 2, in 8% yield. The 1H NMR 
spectrum showed, in addition to all the signals corresponding to the resonance 
of internal protons NH of the macrocycle, ß-pyrrole and S-pyridyl groups, 
signals corresponding to one carbohydrate unit S1 attached to the porphyrin 2. 
Mass spectrometry, MALDI-MS, also confirmed this compound with m/z 1581.1 
(M)+. 
 
Scheme 2.7 
 
 
2.5.2 Coupling of galactose to 5,10,15,20-tetrakis(4-pyridyl) porphyrin  
 
 
 Sugar S1 was coupled to porphyrin 5 with the aim of obtaining a meso-
tetra-substituted galactoporphyrin 6 (Scheme 2.8). The reaction was conducted 
in trichlorobenzene at reflux, for two hours, under nitrogen atmosphere. The 
reaction products were precipitated in n-hexane, filtered through cotton in a 
funnel, washed with n-hexane and collected in chloroform/methanol (95:5). The 
mixture was concentrated and submitted to a column chromatography (silica 
gel) using chloroform/methanol (90:10) as eluent. The purified fraction, obtained 
in a 50% yield, was identified by mass and 1H NMR as being porphyrin 12  
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Scheme 2.8 
 
 
Figure 2.3 1H NMR of compound 12. 
 
 Compound 12 was characterized by 1H NMR and, MALDI-MS. The 1H 
NMR spectrum show the resonance of the protons corresponding to porphyrin 5 
and sugar S1 (Figure 2.3). The first signal at % -3.04 ppm is related to the 
resonance of the NH protons, characteristic of free base porphyrins. The 
aliphatic region shows the signals corresponding to the sugar protons: four 
singlets, corresponding to the resonance of four isopropylidene methyl groups 
at % 1.36, 1.44, 1.54 and 1.55 ppm, and the remaining seven protons between % 
4.42, and 5.64 ppm. The aromatic zone shows one double doublet at % 8.28 
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ppm corresponding to the six ortho protons of the 10,15,20-pyridyl substituents, 
two multiplets at % 8.89-8.94 and 9.05-9.13 ppm corresponding to the eight $-H, 
six 10,15,20-Py-m-H and two 5-Py-o-H and, finally, one duplet at % 9.59 
corresponding to 5-Py-m-H. Mass spectrometry also confirmed this structure by 
the presence of one peak at m/z 861.3 (M+). 
 
 
2.6 Methylation of compounds to use in biological assays 
 
2.6.1 Methylation of glycoporphyrin 12 
 
 The methylation of porphyrin 12 was carried out in dimethylformamide 
(DMF), using a large excess of methyl iodide (Scheme 2.9). The reaction was 
conducted overnight at 40 °C. After cooling of the reaction mixture in ice, the 
product was precipitated by addition of ethyl ether. The solid phase was filtered, 
thoroughly washed with ethyl ether, collected in water/acetone. After, re-
precipitation in acetone/water (90% yield), the mixture was filtered under reduce 
pressure, washed with acetone and dried under vacuum. 
 
Scheme 2.9 
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Figure 2.4 1H NMR of compound 13. 
 
 
The 1H NMR spectrum of 13 (Figure 2.4) is similar to the obtained with 
precursor 12, however in addition to all the signals corresponding to the 
resonance of the macrocycle and the carbohydrate moiety, there was a new 
signal, a singlet at % 4.73 ppm generated by the resonance of the three methyl 
groups. 
 
 
2.6.2 Methylation of porphyrin 5,10,15,20-tetrakis(4-pyridyl)porphyrin (5) 
 
 The methylation of porphyrin 5 was carried out in DMF, using a large 
excess of methyl iodide (Scheme 2.11). The procedure used was similar to the 
described in the previous section. The methylated product (92% yield), was 
filtered under reduce pressure, washed with acetone and dried under vacuum. 
The 1H NMR and mass spectra confirmed the complete alkylation of compound 
14. Also, the 1H NMR spectrum showed a singlet at % 4.73 ppm, generated by 
the resonance of the four methyl groups. 
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Scheme 2.11 
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3.1 Introduction 
 
When a photosensitizer (PS) is irradiated by light in presence of 
molecular oxygen, it generates reactive oxygen species (ROS). Depending on 
the oxidative mechanism, type I or type II, several ROS can be produced, 
among which singlet oxygen (1O2). Singlet oxygen is the most involved ROS in 
microbial photoinactivation caused during antimicrobial photodynamic therapy 
(aPDT) [22]. It is highly cytotoxic, interacting with biological systems and 
causing oxidative stress at different levels. It modifies cellular constituents 
resulting in deadly oxidative damage to the target cell and, ultimately, in cellular 
death. The imbalance between 1O2 production and the ability of biological 
systems to repair the damage, leads to oxidative stress. In fact, several 
environmental conditions (e.g. UV irradiation) are also cause of oxidative stress 
to microbial cells, by producing several ROS, namely hydrogen peroxide and 
hydroxyl radicals [103]. Despite the great advances in the PS used in aPDT, the 
microbial response to 1O2 and the damage that it can cause at cellular level are 
still poorly characterized [104]. However, in the last decade, substantial efforts 
were made towards a better understanding of the mechanisms underlying 
oxidative damage caused by singlet oxygen. The nature of the oxidative 
damage and the cellular targets of photodamage during aPDT are still not 
clearly identified. 
 According to the literature, the main targets of aPDT are external 
microbial structures, cell membranes, and, at the molecular level, proteins, 
lipids and nucleic acids [105,106]. The oxidative damage of membrane lipids by 
1O2 is one of the most referred causes of cell death [107]. The fast diffusion of 
this ROS across the membrane and its short lifetime in aqueous media confirm 
this assumption [107]. As a result, the damage is often exclusively associated 
with peroxidation of lipids, particularity of polyunsaturated fatty acids (PUFA) 
[108]. PUFA are considered as the molecules most sensitive to oxidative and 
photosensitive damages, and are associated with cell death [106]. Peroxidation 
of lipids can greatly alter the physicochemical properties of the membrane lipid 
bilayer, resulting in severe cellular dysfunction [109]. In addition, a variety of 
lipid peroxidation are produced, some of which with adverse and/or beneficial 
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biological effects. One of the most widely used biomarkers for lipid peroxidation 
is Malondialdehyde (MDA) [110]. Several studies have demonstrated that cell 
inactivation in related to an increase in the concentration of MDA [110]. 
However, the relation between the rate of lipid peroxidation and the overall 
inactivation is still not fully established [110]. 
 Microbial photoinactivation can also occur through oxidative damage at 
the protein level. Protein oxidation is also used as a proxy for molecular 
damage, during aPDT. In this case, 1O2 can react directly with the protein or 
with other molecules, such as sugars and lipids, generating products that then 
react with the proteins [111]. Different oxidative modifications can occur in 
proteins, namely the formation of carbonyl groups, oxidation of amino acids, 
formation of glycoxidation adducts, or lipid peroxidation adducts, among others 
[112]. Protein carbonyl content is widely used as both a marker for oxidative 
stress and a measure of oxidative damage [113]. There are several methods to 
quantify carbonyl content. However, the most commonly used method is the 
reaction of carbonyl groups with 2,4-dinitrophenylhydrazine (DNPH) to form a 
protein-bound 2,4-dinitrophenylhydrazone (DNP) [112,113]. This 
spectrophotometric method, developed in the 90’s, has become a standard 
method for quantitative determination of protein carbonylation [114]. At the 
cellular level, when proteins are exposed to 1O2, changes in amino acid chains 
and consequently in protein structure, may occur. As expected, these 
modifications lead to changes at the functional level and disorders in overall cell 
metabolism [103]. 
For this work, two gram positive strains, Brevibacterium sp. and 
Micrococcus sp. were used in aPDT experiments. Both strains were isolated 
from environmental samples and were previously characterized as to their 
resistance to UV inactivation. Brevibacterium sp. and Micrococcus sp were 
chosen for this study because they were, respectively, representative of very 
sensitive and very resistant types to UV-B irradiation experiments (Ana Luisa 
Santos, personal communication), in which oxidative stress underlies the 
inactivation process. While Brevibacterium sp. showed to be susceptible to 
environmental doses of UV-B radiation (0.4 W m-2), Micrococcus sp. was much 
more resistant to UV-B induced inactivation. This led to the hypothesis that 
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strains with different susceptibility to UV-B would also show a different response 
to 1O2 mediated aPDT. The global objectives of this task were the assessment 
of the inactivation potential of the newly synthesised galactoporphyrinic PS and 
the quantification of the damage at the molecular level. 
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3.2 Materials and Methods  
 
3.2.1 Photosensitizers 
 
 For aPDT assays, two cationic PS were used, for which the synthesis is 
described in chapter II: 5,10,15,20-tetrakis(N-methylpyridinium-4-yl)porphyrin 
tetra-iodide referred here as PS 1 and 5-[N-(isopropylidene-6-deoxy-
galactopyranos-6-yl)pyridinium-4-yl]-10,15,20-tris(N-methylpyridinium-4-
yl)porphyrin tetra-iodide referred as PS 2 (Figure 3.1). Each compound stock-
solution was prepared at a concentration of 500 µM in dimethylsulfoxide 
(DMSO). 
 
 
Figure 3.1 Photosensitizer tested in aPDT assays. 5,10,15,20-Tetrakis(N-methylpyridinium-4-
yl)porphyrin tetra-iodide (1) and 5-[N-(Isopropylidene-6-deoxy-galactopyranos-6-yl)pyridinium-4-
yl]-10,15,20-tris(N-methylpyridinium-4-yl)porphyrin tetra-iodide (2). 
 
 
3.2.2 Bacterial strains, growth conditions and preparation of stock-
suspensions 
 
Transformed Escherichia coli for bioluminescence screening 
assays  
 
 A bioluminescent Escherichia coli was kept at 4°C in Triptic Soy Agar 
(TSA, Merck) plates with 100 mg.mL-1 of ampicillin (Amp) and 25 mg.mL-1 of 
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chloramphenicol (Cm) [26]. For the preparation of stock culture, an isolate 
colony was grown aerobically overnight at 26 ºC in 25 mL of Luria Broth (LB, 5 
g of Tryptone, 2.5 g yeast extract, 5 g NaCl, to a final volume of 500 mL H2O) 
under agitation (150 rpm) and stored at 4 ºC. Before each experiment, aliquots 
of stock solution (240 µL) were aseptically transferred to 20 mL of fresh 
medium, with the same quantity of both antibiotics, and grew overnight at 28 ºC 
under agitation (130 rpm).  
 
 
Gram positive bacteria for colony-count assays  
 
Brevibacterium sp. and Micrococcus sp. strains were isolated from 
estuarine water and characterized in a previous works at the Applied and 
Environmental Microbiology Laboratory (Biology Department, University of 
Aveiro) and stored in Plate Count Agar (PCA, Merck) at 4 ºC. For the 
preparation of stock cultures, each isolate was grown aerobically for 24h at  
28 ºC in 25 mL of Triptic Soy Broth (TSB, Merck) under agitation (150 rpm) and 
stored at 4 ºC. Before each experiment, aliquots of stock bacterial culture  
(500 µL) were aseptically transferred to 25 mL of fresh TSB medium and grew 
overnight at 28 ºC under agitation (150 rpm), reaching an optical density 
(OD600) of ( 0.2. To estimate the concentration of CFU in the culture, aliquots 
of 100 !L was serially diluted in phosphate buffered saline (PBS, 4 g NaCl, 0.1 
g KCl, 0.12 g KH2PO4, 0.72 g Na2KPO4, to a final volume of 500 mL H2O, pH 
7.4 ± 0.2), pour-plated in duplicate in PCA (Plate Count Agar, Merck) and 
incubated for 48h at 25 ºC. The concentration CFUs in the initial cultures was 
calculated from the average colony counts in the plates corresponding to the 
most suitable dilution. 
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3.2.3 aPDT experimental setup 
 
 Bacterial suspensions prepared from overnight cultures ((107 CFU mL-1 
of gram positive bacteria and (109 CFU mL-1 of the transformed gram negative 
strain), were ten-fold diluted in PBS to a final concentration of (106 CFU mL-1 
and 108 CFU mL-1, respectively. In all experiments, 3 mL of bacteria suspension 
were aseptically transferred to sterilized glass beakers and the PS was added 
from the stock solution to achieve final concentrations of 0.5, 1 and 5.0 µmol 
dm-3, and a final volume of 30 mL achieved with PBS. After the addition of the 
appropriate volume of porphyrin solution, all beakers were protected from 
accidental light exposure with aluminium foil and allowed to a pre-incubation 
period of 15 minutes in the dark under 100 rpm stirring at room temperature 
(25-27 ºC). 
 
 
3.2.4 Irradiation conditions 
 
 Following the pre-incubation period, all samples were exposed to white 
light at a fluence rate of 150 mW cm-2 (measured with a light meter LI-COR 
Model LI-250, Li-Cor inc., USA), for 15 minutes at 25 ºC, under magnetic 
stirring. This photoinactivation protocol was used for each of the two porphyrins 
tested and for the three bacterial strains under investigation. 
 
 
3.2.5 Bioluminescence screening assays 
 
The bioluminescent strain was used for the preliminary screening of the 
performance of the glycoporphyrin PS. A standard volume (500 µL) was 
collected at each time and, if necessary, serially diluted in PBS before 
bioluminescence was read. To convert light emission units in CFU mL-1, a 
standard pre-defined calibration curve was used (Figure 3.2). The correlation 
obtained between bioluminescence signal and viable counts showed that 105 
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RLU mL-1 (initial bacterial luminescence) correspond, approximately, to 108 
CFU mL-1. 
Figure 3.2 Relationship between bioluminescence and viable counts of a growing culture of 
recombinant E. coli. Bioluminescence is expressed in relative light units (RLU) and viable 
counts in CFU mL!1 [115]. 
 
 
3.2.6 Quantification of colony forming units 
 
 The time-course of the inactivation of the gram positive strains was 
assessed by periodically collecting aliquots of the cell suspensions for CFU 
determinations during the irradiation period. A standard volume (100 µL) was 
collected at each sampling moment (time 0 and 2, 5, 10 and 15 minutes 
irradiation), serially diluted in PBS and pour-plated in duplicate in PCA. 
Colonies were counted after 48h of incubation at 25 ºC, in the dark, on the most 
suitable dilution. The concentration of viable cells was estimated from the 
average value of CFU mL-1 and corrected with the dilution factor. For each 
porphyrin and for each bacterial strain, two independent assays were 
conducted and the results expressed as an average. The survival curves were 
constructed by plotting log CFU mL-1 against irradiation time, in minutes. 
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3.2.7 Controls 
 
Light and dark controls were included in all experiments. The light 
controls consisted on a bacterial suspension in PBS (without PS) that followed 
the same irradiation protocol as the tests. The dark controls were composed of 
bacterial suspensions in PBS added of the highest tested concentration of PS 
(5 µmol dm-3) and protected from light with aluminium foil throughout the 
experiments. Both controls followed the pre-incubation protocol in the dark, and 
dark controls were kept in the dark during the following steps of the procedure, 
including plating.  
 
 
3.2.8 Photostability studies of PS 1 and 2 
 
An aliquot of 2 mL of a water solution of PS in a glass cuvette 
(absorbance around 1) was irradiated under the same conditions used in 
biological assays (white light, 400-800 nm, 150 mW cm-2 for 30 minutes), at 
room temperature and under gentle magnetic stirring. The absorption spectrum 
of each sample, at different irradiation periods of time (0, 1, 2, 3, 4, 6, 8, 10, 30 
minutes) was recorded in order to monitor possible changes in their 
spectroscopic behaviour. Two independent experiments were performed for 
each assay. 
 
 
3.2.9 Singlet oxygen generation studies.  
 
An aliquot of 2 mL of a solution of the porphyrin (0.5 µmol dm-3) and 3-
diphenylisobenzofuran (DPiBF, 50 µmol dm-3) in DMF/H2O (9:1) were irradiated 
with white light filtered through a cut-off filter for wavelengths <540 nm, at a 
fluence rate of 9.0 mW cm-2 in a glass cuvette, at room temperature and under 
gentle magnetic stirring, for different periods of time. Stock solutions of DPiBF 
were prepared at a concentration of 10 mmol dm-3 in DMF/H2O (9:1). The 
absorption decay of DPiBF at 415 nm was measured at irradiation intervals of 
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time up to 20 min. The percentage of the absorption decay is proportional to the 
production of 1O2, and was calculated by comparison of the initial absorbance of 
the solution and the absorbance after a given period of irradiation. 
 
 
3.2.10 Indicators of bacterial oxidative stress  
 
3.2.10.1 Lipid oxidation  
 
 The formation of malondialdehyde (MDA) was used as an index to 
measure lipid peroxidation, followed the methodology proposed by Gonsález-
Flecha et al. [116]. MDA was quantified based on its reaction with thiobarbituric 
acid (TBA) to form a pink MDA-TBA adduct. Thiobarbituric acid (TBA) reagent 
[trichloroacetic acid (TCA, 4.28 mL of 70% TCA, VWR), TBA (75 mg, Fluka), 2 
mol dm-3   HCl (2.5 mL) make up to 20 mL with distillate H2O] was added to a 
standard volume (500 µL) of the irradiated cell suspensions, corresponding to 
the highest PS concentration (5 µmol dm-3 of porphyrin), and control samples. 
Each sample was heated at 100 ºC during 15 minutes and, after cooled, was 
centrifuged (Heraeus Pico 17 Centrifuge) for 5 minutes at 10.000 g to remove 
debris. The absorbance was read at 535 nm (Genesys 6) against a standard. In 
the case of experimental samples and dark controls, the standard was 5 µmol 
dm-3 of PS in 500 µL of PBS and 500 µL TBA reagent. In the case of light 
control, the standard used was 500 µL of PBS and 500 µL of TBA reagent. To 
assess the amount of MDA produced, a calibration curve with several MDA 
concentrations (0, 0.5, 1, 1.5, 2.0, 3.0, 4.0 and 5.0 nmol dm-3) were constructed 
(Figure 3.3). To this, MDA (Sigma) was diluted in TBA reagent to the desired 
concentrations. 1 mL of each concentration was incubated at 100 ºC for 15 
minutes. Absorbance was read at 535 nm (Genesys 6). Results were expressed 
in terms of amount of MDA (nmol dm-3). The percentage of MDA produced, 
during irradiation, relatively to the MDA value obtained without irradiation was 
also calculated. 
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Figure 3.3 Relationship between absorbance and MDA concentration. MDA concentration is 
expressed in nmol dm-3. 
 
3.2.10.2 Protein oxidation  
 
The protein oxidation was evaluated trough the quantification of carbonyl 
groups, followed the methodology proposed by Gonsález-Flecha et al. [116]. 
The content of carbonyl groups in oxidatively modified proteins was measured 
by determining the amount of 2,4-dinitrophenyl hydrazone (DNP) formed upon 
reaction with 2,4-dinitrophenylhydrazine (DNPH). 
Protein oxidation was determined with 5 µmol dm-3 of porphyrin and in 
control samples. Cells suspensions were homogenized on ice and stored in 2 
mL microtubes at -80 ºC (Snijders scientific) until analysis. Prior to analysis, 
each sample thawed and incubated with either 10 mmol dm-3 DNPH (Sigma, 
425 mg of DNPH in 250 mL of 2 mol dm-3 HCl, test samples) or with 2 mol dm-3 
HCl (controls) The mixture was incubated in the dark for 1 hour, vortexing 
(Labinco L46) every 15 minutes. After incubation, proteins were precipitated 
with 1 mL of 20% (weight/volume) TCA (Sigma) and incubated on ice for 5 
minutes. The mixture was centrifuged (Heraeus Pico 17) at 10.000 g, for 10 
minutes and the supernatant were discarded. The pellet was ressuspended in 1 
mL 10% (weight/volume) TCA (Sigma). The reaction mixture was further 
incubated on ice for 5 minutes and was centrifuged (Heraeus Pico 17) during 10 
minutes at 10.000 g. Samples were washed 3 times with 1 mL of 1:1 
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(volume/volume) ethanol/ethyl acetate and subsequently dissolved in 1 mL of 6 
mol dm-3 guanidine hydrochloride (Sigma) [103 g of guanidine hydrochloride in 
180 mL of potassium phosphate (20 mmol.dm-3; 0.7 g to 200 mL)]. The mixture 
was further centrifuged (Heraeus Pico 17) at 10.000 g for 10 minutes. The 
absorbance of samples and controls was read at 370 nm (Genesys 6) and 
guanidine was used as standard. 
Results were expressed as nmol mL-1 of protein carbonyl that was 
calculated from a molar coefficient of 21.0 mmol-1 dm-3 cm-1. For this we used 
the following formula (Figure 3.4), where SC is the difference between the 
sample and control absorbance, and 1 is the cuvette length (cm) used to read 
absorbance. 
 
 
Figure 3.4 Formula used to calculate the protein carbonyl concentrations. 
  
Protein Carbonyl Conc. = [(SC)/(0.021 x 1)] x (final volume of guanidine/initial volume of sample) 
          (nmol cm-3) 
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3.3 Results and Discussion 
 
3.3.1 Photoinactivation experiments 
 
3.3.1.1 Screening assays with bioluminescent Escherichia coli 
 
The inactivation kinetics of a transformed bioluminescent E. coli was 
used as an initial screening to determine the photoinactivation potential of the 
two synthesised porphyrins. The variations of the viability of the E. coli culture 
calculated from light emission, in presence of each PS, during the irradiation 
experiments with artificial light are displayed in Figure 3.5. Both PS showed 
good inactivation effect after 15 minutes of irradiation. PS 2 showed slightly 
better results than PS 1. In terms of reduction of viability of the bioluminescent 
strain, PS 1 caused a 2.0 log reduction and PS 2 caused a 3.0 log reduction. 
Dark and light controls confirm that bacterial viability was neither directly 
affected by light nor by the PS tested in the dark at a concentration of  
5 µmol dm-3. This indicates that the results obtained during aPDT assays were 
due to the PS photosensitizing effect. 
 
 
 
Figure 3.5 Variation of the concentration of viable bioluminescent E. coli during PDI experiments with  
5 !mol dm-3 of PS 1 and 2 using white light at a fluence rate of 150 mW.cm-2. Values correspond to the 
average of two independent experiments. Error bars represent the standard deviation. (—!—light control, 
— ! —dark control PS 1, —!—dark control PS 2, — " — PS 1, — x —PS 2). 
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Previous studies have shown that cationic porphyrins are more effective 
against bacteria, viruses, fungi and protozoa than the anionic and neutral ones, 
due to its interaction with negatively charged sites existing on cell surfaces 
[59,29]. The better performance of PS 2 may be explained by the presence of 
the carbohydrate unit. In addition to the characteristics acquired by the 
presence of positive charges, the protected carbohydrate unit provides 
molecular asymmetry to PS 2, creating hydrophilic/hydrophobic ratios and 
greater permeability [85].  
If the carbohydrate unit in PS 2 were in the free form, i.e. the hydroxyl 
groups without the protective isopropylidene groups, a more efficient 
photoinactivation could be expected since the existence of -OH groups allows 
the PS to better interact with the membrane, facilitating its penetration into the 
cell [84,90, 101].  
 
 
3.3.1.2 Photodynamic inactivation of Micrococcus sp and 
Brevibacterium sp. 
 
The kinetics of inactivation of Micrococcus sp. during the irradiation 
experiments with artificial light in the presence of PS 1 and 2 is represented in 
Figure 3.6. After 2 minutes of irradiation in the presence of 5 µmol dm-3 of PS, 
inactivation was complete. However, differences in the performance of the two 
porphyrins can be detected in results obtained with lower concentrations. After 
2 minutes of irradiation, 0.5 and 1 µmol dm-3 of porphyrin 1 caused reductions 
of 3.9 and 6.9 log in CFU concentration, respectively. Porphyrin 2 caused 
slightly lower reduction: 3.6 and 5.3 log reductions with 0.5 and 1 µmol dm-3, 
respectively. These results show that, for the lowest concentrations, porphyrin 1 
is more effective against Micrococcus sp. than porphyrin 2, contrasting with the 
results of the screening test in bioluminescent E. coli.  
The profile of inactivation of Brevibacterium sp. in the presence of PS 1 
and 2 during experiments of irradiation with artificial light, is presented in Figure 
3.5. Total inactivation occurred after 2 minutes of irradiation in the presence of 5 
µmol dm-3 of PS 1 and 2. Differences between the two PS can be observed in 
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the early stages of irradiation, in the presence of lower PS concentrations. After 
2 minutes of irradiation, 0.5 and 1 µmol dm-3 of porphyrin 1 caused 2.9 and 3.9 
log reductions, respectively, while with 0.5 and 1 µmol dm-3 of porphyrin 2 the 
corresponding reductions were 2.1 and 2.9 log, respectively.  
 
  
  
Figure 3.6 Variation of the concentration of CFU in Micrococcus sp. (upper charts) and Brevibacterium sp. 
(lower charts) cell suspensions during PDI experiments with 0.5, 1 and 5 !mol dm-3 of PS 1 and PS 2, 
using white light at a fluence rate of 150 mW.cm-2. Values correspond to the average of two independent 
experiments. Error bars represent standard deviation. (—!—light control, — " —dark control, —!—0.5 
!mol dm-3, —x—1 !mol dm-3, — " —5 !mol dm-3).  
 
 
Both PS showed a good potential for the inactivation of the two selected 
environmental strains, Micrococcus and Brevibacterium. In fact, both strains 
were totally inactivated with the highest concentration tested (5 !mol dm-3), 
after 2 minutes of irradiation. The Brevibacterium strain used in this study was 
very susceptible to UV-B irradiation, in contrast with Micrococcus strain, which 
exhibited higher resistance. (Ana Luisa Santos, Personal Communication). 
0 
1 
2 
3 
4 
5 
6 
7 
8 
0 2 5 10 15 C
o
n
c
e
n
tr
a
ti
o
n
 o
f 
v
ia
b
le
 c
e
ll
s
 
(l
o
g
 C
F
U
 m
L
-1
) 
Irradiation time (min) 
PS 1 
Chapter III – In vitro effects of galactoporphyrins in environmental bacterial 
strains 
 63 
Considering that ROS also mediate UV-B induced damage, it could be 
expected that these strains would reveal distinct susceptibility to aPDT using 
porphyrins as PS. However the relative contribution of different ROS in the two 
processes is different. aPDT is mostly mediated by 1O2 whereas UV-B 
inactivation involves mainly the OH. This may explain why the two strain are 
differently inhibited by UV-B but are almost equally susceptible to aPDT. Both 
strains belong to the Actinobacteria group, that includes gram positive bacteria 
with high GC content, that are also considered to be less susceptible to damage 
at the DNA level [117]. However, gram positive bacteria are more susceptible to 
PDI with porphyrins that gram negative strains. The different response of the 
test strains to UV-B and to aPDT, points out to the relevance of other 
subcellular targets rather than the bacterial nucleoid. The increased 
susceptibility of gram positive bacteria has been mainly attributed to the 
composition and structure of the cell wall. The presence of a cytoplasmic 
membrane surrounded by a thick, although porous, layer of peptidoglycan and 
teichoic acids in gram positive bacteria allows a stronger bond with the PS 
molecules. In contrast, the outer membrane of gram negative bacteria 
decreases PS adsorption and overall cell permeability [59]. 
Looking to the inactivation profile obtained with the lowest PS 
concentrations, differences in the inactivation rates induced by the two tested 
PS and in the susceptibility of the two strains can be detected. According to the 
overall susceptibility to both PS, Micrococcus can be considered as more 
susceptible than Brevibacterium. For each of the tested strains, PS 1 produces 
a more efficient inactivation than PS 2. The results show a trend that is opposite 
from that observed in the bioluminescence screening tests, in which PS 2 was 
more effective than PS 1. However, the bioluminescent strain is a genetically 
transformed E. coli, a gram negative bacteria, with a susceptibility to aPDT that 
is most likely different from the tested gram positive environmental strains.  
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3.3.2 Photostability of PS 1 and 2 
 
In order to establish the rate of photodegradation of the porphyrinic 
compounds, the photostability studies were conducted in conditions of 
irradiation similar to those used in the biological assays (white light, 150 mW 
cm-2). The photostability of PS 1 and 2, solutions of 5 and 3 µmol dm-3, 
respectively, was evaluated in PBS solutions in order to better represent the 
conditions of the biological evaluation experiments. The results are presented in 
Figure 3.7 and summarised in Table 3.1.  
Both compounds show a high photostability during the 15 min of 
irradiation. The low photobleaching of the compounds indicates that they do not 
undergo extensive destruction of the tetrapyrrolic macrocycle. The photostability 
of the compounds is an important parameter to ensure that the biological 
effected determined can be directly related with the initial concentration of the 
drugs. 
 
  
Figure 3.7 Absorbance spectra of PS 1 and 2 after irradiation with white light (150 mW.cm-2) for 
different periods of time. 
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Table 3.1. Photostability of the photosensitizers after irradiation with white light (150 mW cm-2) for different 
periods of time. The results are presented in percentage calculated by the ratio of residual absorbance at 
different periods of time and the absorbance before irradiation. The absorbance was measured at the 
corresponding Soret band wavelength. 
 
 
 
3.3.3  Singlet oxygen production of PS 1 and 2 
 
The capacity of the new porphyrin derivatives to generate singlet oxygen 
was qualitatively estimated by measuring the absorption decay of 1,3-
diphenylisobenzofuran (DPIBF) at 415 nm and used as an indication of their 
potential to act as photosensitizers. All tests were conducted in DMF/H2O (9:1), 
in order to have a polar system to dissolve the PS (0.5 µmol dm-3) and at the 
same time dissolve the DPiBF (50 µmol dm-3).  
DPiBF photodegradation upon irradiation with white light filtered through 
a cut-off filter for wavelengths <540 nm (9 mW cm-2) was much higher in the 
presence of the photosensitizers (Figure 3.8). These results confirm that both 
PS are good singlet oxygen generators, showing a decrease DPiBF absorption 
around 77% and 73% for compound 1 and 2, respectively, within 15 minutes of 
irradiation. PS 2 showed a slightly higher 1O2 production in the first 9 minutes. 
After that, the observed absorbances are related to the different epsilon of the 
PS in solution.  
 
PS 0 1 2 3 4 6 8 10 30
1 100 99 98 97 97 97 97 97 97
2 100 99 98 98 98 98 97 97 96
Irradiation time (min)
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Figure 3.8 Relative decrease in absorption as a measure of photooxidation of DPiBF (50 µmol dm-3) in 
DMF/H2O (9:1) upon irradiation with white light filtered through a cut-off filter for wavelengths <540 nm (9 
mW cm-2) with or without photosensitizer 1 and 2 (0.5 µmol dm-3). Values correspond to the average of two 
independent experiments. (—!—DPiBF, —!—PS 1, —!—PS 2) 
 
 
3.3.4 Lipid oxidation in Micrococcus sp. and Brevibacterium sp. 
 
The studies to quantify lipid peroxidation in both gram-positive bacteria 
were undertaken with the concentration of PS 1 or 2 with better inactivation rate 
effect (5 !mol dm-3). The effects of irradiation on MDA formation in Micrococcus 
sp. and Brevibacterium sp. are presented in Figure 3.9 and Table 3.2.  
The two PS tested produced different results. While in the case of PS 1 
MDA production in Micrococcus was not affected, PS 2 there caused a 31% 
increase of MDA concentration during the irradiation time. This corresponded to 
an increase of 0.085 nmol dm-3 of MDA relatively to the initial MDA 
concentration. 
 During the irradiation of Brevibacterium cells in the presence of 5 µmol 
dm-3 of each PS, there was an increase in the concentration of MDA, that was 
not detected in dark and light controls. After 15 minutes of irradiation, in 
presence of PS 1, there was a 28% increase in MDA concentration and with PS 
2 the increase was by 50%, relatively to the amount of MDA determined at the 
beginning of the irradiation. After 15 minutes of irradiation in the presence of PS 
1, approximately 0.073 nmol dm-3 of MDA was extracted while with PS 2, the 
concentration of MDA was 0.093 nmol dm-3.  
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Figure 3.9 Lipid peroxidation kinetics in Micrococcus sp. (upper charts) and Brevibacterium sp. (down 
chart) by PS 1 and 2. Cell suspensions were treated with PS 1 and 2 (5 µmol dm-3) and white light (150 
mW cm-2) for a maximum of 15 minutes. Lipid peroxidation was quantified by the TBA assay. Values 
correspond to the average of 2 independent experiments. Error bars represent the standard deviation. 
[Left to Right: Light Control (Blue), Dark Control (Red) and 5 µmol dm-3 of PS (Green)]. 
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Table 3.2 Concentration of MDA (nmol dm-3) at 0 and 15 minutes and the concentration of MDA produced 
during the aPDT assays (difference between the final and initial MDA concentrations). 
 
Strains PS 
Assay 
condition 
Time 0 min 
[MDA]  
(nmol dm-3) 
Time 15 min 
[MDA]  
(nmol dm-3) 
(T0-T15) 
[MDA] 
(nmol dm-3) 
B
re
v
ib
a
c
te
ri
u
m
 
sp
. 
1 
L.C. 0.19 0.19 0 
D.C. 0.21 0.21 0 
5 !mol dm-3 0.23 0.31 0.073 
2 
L.C. 0.19 0.19 0 
D.C. 0.21 0.21 0 
5 !mol dm-3 0.19 0.28 0.093 
M
ic
ro
c
o
c
c
u
s
 
sp
. 
1 
L.C. 0.31 0.31 0 
D.C. 0.41 0.41 0 
5 !mol dm-3 0.34 0.34 0 
2 
L.C. 0.31 0.31 0 
D.C. 0.41 0.41 0 
5 !mol dm-3 0.33 0.41 0.085 
 
 
The enhanced MDA formation indicates that lipid peroxidation occurred, 
especially of polyunsaturated fatty acids (PUFA) [108]. The increase of this 
compound over time shows that the lipids damage is cumulative. These lipids, 
found in large amounts in gram positive bacteria, are located in the 
citoplasmatic membrane. The increased of MDA can, therefore, be related to 
progressive membrane damage during irradiation, indicating that this cellular 
structure is one of targets of 1O2 damage. Taking into account the 
1O2 short 
lifetime and consequently reduced dislocation, plasmatic membrane may 
actually be the major PS target. Previous shown that 1O2 may cause damage in 
the cell membrane leading to the leakage of cellular material to the extracellular 
medium [107]. Although PS 2 differently affected MDA production in the two 
bacterial strains tested, it caused lipid oxidation in both of them. This can be 
related to the asymmetric PS that has a higher amphiphilic character than PS 1, 
due to the presence of the carbohydrate unit.  
 
 
 
 
 
 
Chapter III – In vitro effects of galactoporphyrins in environmental bacterial 
strains 
 69 
3.3.5 Protein oxidation of Micrococcus sp. and Brevibacterium sp. 
 
Proteins carbonylation is a type of protein oxidation, promoted in this 
case by 1O2, that indicates the occurrence of oxidative stress. Despite the 
changes behind the biological oxidation of proteins remaining unknown, protein 
carbonyl and chemical reactions behind the carbonyl groups are well 
characterized. When proteins are exposed to 1O2, various kinds of damage at 
the amino acid chain occur, leading to a change at the protein level. In turn, 
these changes lead to changes in protein function causing disorders at the 
cellular level. 
 The effect of PS 1 and 2 protein carbonyls formation in Micrococcus sp. 
and Brevibacterium sp. are represented in Figure 3.10. During the irradiation 
time, the presence of 5 µmol dm-3 of each of the PS, caused an increase 
concentration of protein carbonyls in Micrococcus. This was not observed in 
dark and light controls. After 15 minutes of irradiation in the presence of PS 1, 
approximately 2.2 nmol mL-1 of carbonyl protein was extracted. Dark and light 
control, only presented 0.08 and 0.08 nmol mL-1 of carbonyl protein, 
respectively. With PS 2 approximately 6.1 nmol mL-1 of carbonyl protein were 
extracted while dark and light control both presented 0.09 nmol mL-1 of carbonyl 
protein. 
 In Brevibacterium, PS 1 and 2 caused an increase of protein carbonyls 
concentration after 15 minutes of irradiation with 5 µmol dm-3 of PS. In the case 
of dark and light controls only slight increase of protein carbonyls is observed, 
during the irradiation time. After 15 minutes of irradiation in the presence of PS 
1, approximately 5.1 nmol mL-1 of carbonyl protein. Dark and light control, 
presented concentration of approximately 0.06 and 0.12 nmol mL-1 of carbonyl 
protein, respectively. With PS 2, the DNPH concentrations were approximately 
4.8 nmol mL-1 of carbonyl protein. In both dark and light controls, the 
corresponding concentrations were 0.09 nmol mL-1 of carbonyl protein. 
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Figure 3.10 Protein oxidation kinetics in Micrococcus sp. (upper charts) and Brevibacterium sp. (down 
charts) by PS 1 and 2. Cell suspensions were treated with 5 µmol dm-3 of PS 1 and PS 2 and white light 
(150 mW cm-2) for a maximum of 15 minutes. Protein oxidation was quantified using DNPH. Values 
correspond to the average of two independent experiments [left to right: Light Control (Blue), Dark Control 
(Red) and 5 µmol dm-3 of PS (Green)]. 
 
 
The variation of protein carbonyls concentration was different depending 
on the bacteria and on the PS. In Brevibacterium both PS (1 and 2) cause the 
same concentration of protein carbonyls, ) 5 nmol mL-1 while, with Micrococcus 
there is a difference in the production of carbonyls dependent of the PS, ) 2 
nmol mL-1 in the case of PS 1 and ) 6 nmol mL-1 in the case of PS 2. 
These studies show that both PS caused damage in protein constituents 
of the cell. However, this damage can be indirectly caused by decomposition of 
PUFA. Indeed, lipid peroxidation can initiate a reaction chain leading to 
formation of a variety of carbonylated species. Considering this fact, the results 
of protein oxidation in Micrococcus are consistent with those describing lipid 
peroxidation. PS 2 caused greater lipid damage and also caused greater 
protein damage. PS 1, showed very little effect in lipids but caused protein 
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oxidation suggesting that that damage at the protein levels could be caused by 
direct interaction of 1O2 with the amino acid chains.  
In Brevibacterium this effect is not so clear because both PS caused 
damage at both protein and lipid levels. The fact that the PS 1 induces the 
formation of slightly higher concentrations of proteins carbonyls than the PS 2, 
corresponds to a trend that is opposite to that observed in lipid peroxidation and 
may also indicate that the damage was caused by direct interaction with 1O2 or 
by a combination of both effects (direct and indirect). 
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The synthesis of a new cationic galactoporphyrin was successfully 
achieved, allowing a water soluble compound capable of acting as PS in aPDT 
assays. 
aPDT results showed that both PS tested had good effects of 
photoinactivation in both gram positive and gram negative bacteria. However, the 
gram negative bacteria was more resistant to photoinactivation than the gram 
positive one. The carbohydrate unit confers an amphiphilic character to the 
molecule, allowing the improvement in permeability of PS in both hydrophilic and 
lipophilic structures. 
The two environmental bacteria (gram positive) tested showed different 
susceptibility to aPDT assays than those previously observed, when exposed to 
UV-B irradiation. While with UV-B irradiation Brevibacterium was much more 
susceptible than Microccocus to photinactivation, in the case of aPDT an equal 
susceptible were observed when exposed to 5 !mol dm-3 of PS. However, at lower 
concentrations, the Micrococcus showed to be more susceptible than 
Brevibacterium. These results showed that the singlet oxygen, produced during 
aPDT, causes different damages in these two bacteria compared with the hydroxyl 
radical, produced during the UV-B irradiation. 
Relatively to the oxidation of lipids, Brevibacterium suffered major damage 
at the level of polyunsaturated fatty acids, indicating that for this environmental 
bacteria both PS act at the plasma membrane. In the case of Micrococcus, only 
the PS with the carbohydrate unit showed damage at the plasma membrane, 
being however, lower than those observed for Brevibacterium. 
The influence of lipid peroxidation on oxidation damage of proteins is well 
documented, allowing us to hypothesize that the damage may have been due to 
oxidation of lipids, in the case of Brevibacterium and Micrococcus with PS 2. 
However, the existence of protein oxidation in the presence of a PS that has not 
caused any damage suggests that this damage can be caused in part by direct 
interaction of 1O2 with proteins.  
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